| Outgoing Relation(s) |
| antineoplastic agent (CHEBI:35610) is a drug (CHEBI:23888) |
| Incoming Relation(s) |
| (+)-albicanol (CHEBI:155904) has role antineoplastic agent (CHEBI:35610) |
| (+)-aplysinillin (CHEBI:65417) has role antineoplastic agent (CHEBI:35610) |
| (+)-dexrazoxane (CHEBI:50223) has role antineoplastic agent (CHEBI:35610) |
| (+)-dihydromyricetin (CHEBI:28429) has role antineoplastic agent (CHEBI:35610) |
| (+)-flavipucine (CHEBI:156436) has role antineoplastic agent (CHEBI:35610) |
| (+)-halomon (CHEBI:147399) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide V (CHEBI:68278) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide W (CHEBI:68279) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide Z1 (CHEBI:68274) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide Z2 (CHEBI:68275) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide Z5 (CHEBI:68280) has role antineoplastic agent (CHEBI:35610) |
| (+)-jasplakinolide Z3 (CHEBI:68276) has role antineoplastic agent (CHEBI:35610) |
| (+)-lyoniresinol (CHEBI:68168) has role antineoplastic agent (CHEBI:35610) |
| (+)-sesamin (CHEBI:66470) has role antineoplastic agent (CHEBI:35610) |
| (+)-syringaresinol (CHEBI:47) has role antineoplastic agent (CHEBI:35610) |
| (+)-tephrorin A (CHEBI:66199) has role antineoplastic agent (CHEBI:35610) |
| (+)-tephrorin B (CHEBI:66200) has role antineoplastic agent (CHEBI:35610) |
| (+)-tephrosone (CHEBI:66201) has role antineoplastic agent (CHEBI:35610) |
| (+)-δ-cadinol (CHEBI:184119) has role antineoplastic agent (CHEBI:35610) |
| (E,E)-germacrone (CHEBI:80830) has role antineoplastic agent (CHEBI:35610) |
| (E)-trans-miyabenol C (CHEBI:76193) has role antineoplastic agent (CHEBI:35610) |
| (E)-2-[[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]hydrazinylidene]methyl]benzoic acid (CHEBI:167669) has role antineoplastic agent (CHEBI:35610) |
| (R,R,S)-lobaplatin (CHEBI:194425) has role antineoplastic agent (CHEBI:35610) |
| (R)-amygdalin (CHEBI:17019) has role antineoplastic agent (CHEBI:35610) |
| (R)-bicalutamide (CHEBI:39589) has role antineoplastic agent (CHEBI:35610) |
| (R)-homocamptothecin (CHEBI:144047) has role antineoplastic agent (CHEBI:35610) |
| (S,S,S)-lobaplatin (CHEBI:194426) has role antineoplastic agent (CHEBI:35610) |
| (S)-glaucine (CHEBI:5373) has role antineoplastic agent (CHEBI:35610) |
| (−)-(S)-chlorizidine A (CHEBI:156431) has role antineoplastic agent (CHEBI:35610) |
| (−)-anisomycin (CHEBI:338412) has role antineoplastic agent (CHEBI:35610) |
| (−)-annonaine (CHEBI:76) has role antineoplastic agent (CHEBI:35610) |
| (−)-antofine (CHEBI:143911) has role antineoplastic agent (CHEBI:35610) |
| (−)-coronaridine (CHEBI:3887) has role antineoplastic agent (CHEBI:35610) |
| (−)-demecolcine (CHEBI:4393) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne (CHEBI:67754) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne B (CHEBI:67755) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne C (CHEBI:67756) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne D (CHEBI:67757) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne E (CHEBI:67758) has role antineoplastic agent (CHEBI:35610) |
| (−)-duryne F (CHEBI:67759) has role antineoplastic agent (CHEBI:35610) |
| (−)-epigallocatechin 3-gallate (CHEBI:4806) has role antineoplastic agent (CHEBI:35610) |
| (−)-flavipucine (CHEBI:156437) has role antineoplastic agent (CHEBI:35610) |
| (−)-gallocatechin gallate (CHEBI:156271) has role antineoplastic agent (CHEBI:35610) |
| (−)-jasplakinolide Z4 (CHEBI:68277) has role antineoplastic agent (CHEBI:35610) |
| (−)-marinopyrrole A (CHEBI:66678) has role antineoplastic agent (CHEBI:35610) |
| (−)-noscapine (CHEBI:73237) has role antineoplastic agent (CHEBI:35610) |
| (−)-phenylahistin (CHEBI:192360) has role antineoplastic agent (CHEBI:35610) |
| (−)-voacangine (CHEBI:141966) has role antineoplastic agent (CHEBI:35610) |
| (−)-β-elemene (CHEBI:62855) has role antineoplastic agent (CHEBI:35610) |
| (1,2-diaminocyclohexane)PtCl2 (CHEBI:90269) has role antineoplastic agent (CHEBI:35610) |
| (1R,2R,4S,5S,6R,7S)4,5-epoxygermacra-9Z-en-1,2,6-triol (CHEBI:66168) has role antineoplastic agent (CHEBI:35610) |
| (13R)-13-dihydrocarminomycin (CHEBI:31058) has role antineoplastic agent (CHEBI:35610) |
| (2→6)-β-D-fructan (CHEBI:16703) has role antineoplastic agent (CHEBI:35610) |
| (2S)-(−)-kurarinone (CHEBI:66150) has role antineoplastic agent (CHEBI:35610) |
| (2S)-1-O-(7Z,10Z,13Z)-hexadecatrienoyl-2-O-(7Z,10Z)-hexadecadienoyl-3-O-β-D-galactopyranosyl-sn-glycerol (CHEBI:83004) has role antineoplastic agent (CHEBI:35610) |
| (2S)-1-O-(7Z,10Z)-hexadecadienoyl-2-O-(7Z,10Z)-hexadecadienoyl-3-O-β-D-galactopyranosyl-sn-glycerol (CHEBI:83005) has role antineoplastic agent (CHEBI:35610) |
| (2S)-1-O-(7Z,10Z)-hexadecadienoyl-2-O-linoleoyl-3-O-β-D-galactopyranosyl-sn-glycerol (CHEBI:83006) has role antineoplastic agent (CHEBI:35610) |
| (2S)-1-O-(9Z,12Z)-octadecadienoyl-2-O-(7Z,10Z)-hexadecadienoyl-3-O-(α-D-galactopyranosyl(1→6)-β-D-galactopyranosyl)-sn-glycerol (CHEBI:83007) has role antineoplastic agent (CHEBI:35610) |
| (2S)-2'-hydroxy-7,8,3',4',5'-pentamethoxyflavan (CHEBI:66036) has role antineoplastic agent (CHEBI:35610) |
| (2S)-2'-methoxykurarinone (CHEBI:66151) has role antineoplastic agent (CHEBI:35610) |
| (2S)-5-Hydroxy-7-methoxy-8-[(E)-3-oxo-1-butenyl]flavanone (CHEBI:66031) has role antineoplastic agent (CHEBI:35610) |
| (2S)-5,7-dimethoxy-8-(2S-hydroxy-3-methyl-3-butenyl)-3',4'-methylenedioxyflavanone (CHEBI:65796) has role antineoplastic agent (CHEBI:35610) |
| (2S)-5,7-dimethoxy-8-formylflavanone (CHEBI:65795) has role antineoplastic agent (CHEBI:35610) |
| (2S),(2''S)-8,8''-5'-trihydroxy-7,7''-3,3''-4,4''-5''-heptamethoxy-5,5''-biflavan (CHEBI:66413) has role antineoplastic agent (CHEBI:35610) |
| (2S),(2''S)-8,8''-5',5''-tetrahydroxy-7,7''-3,3''-4,4''-hexamethoxy-5,5''-biflavan (CHEBI:66414) has role antineoplastic agent (CHEBI:35610) |
| (20S)-ginsenoside Rg3 (CHEBI:67991) has role antineoplastic agent (CHEBI:35610) |
| (20S)-ginsenoside Rh2 (CHEBI:77147) has role antineoplastic agent (CHEBI:35610) |
| (22E,24R)-5α,8α-epidioxyergosta-6,9,22-triene-3β-ol-3-O-β-D-glucopyranoside (CHEBI:65852) has role antineoplastic agent (CHEBI:35610) |
| (25R)-5β-spirostan-3β-ol (CHEBI:28933) has role antineoplastic agent (CHEBI:35610) |
| (3S)-3-{[3',4'-difluoro-5-({4'-fluoro-6-[(3S)-pyrrolidinium-3-yloxy][biphenyl]-3-yl}carbamoyl)[biphenyl]-2-yl]oxy}pyrrolidinium dichloride (CHEBI:146308) has role antineoplastic agent (CHEBI:35610) |
| (3β,16α)-16-hydroxy-13,28-epoxyoleanan-3-yl α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-arabinopyranoside (CHEBI:66425) has role antineoplastic agent (CHEBI:35610) |
| (4Z,7Z,10Z,13Z,15E,19Z)-17-oxodocosahexaenoic acid (CHEBI:140238) has role antineoplastic agent (CHEBI:35610) |
| (4βH)-5α-hydroxy-8α-(2-methylbut-2-enoyloxy)-2-oxo-1(10),11(13)-guaiadien-12,6α-olide (CHEBI:65832) has role antineoplastic agent (CHEBI:35610) |
| (4βH)-8α-(2-methylbut-2-enoyloxy)-2-oxo-1(5),10(14),11(13)-guaiatrien-12,6α-olide (CHEBI:65833) has role antineoplastic agent (CHEBI:35610) |
| (5,6-dimethyl-1,10-phenanthroline)(1S,2S-diaminocyclohexane)platinum(II)(2+) (CHEBI:83153) has role antineoplastic agent (CHEBI:35610) |
| (5Z,9Z,12Z)-octadecatrienoic acid (CHEBI:86136) has role antineoplastic agent (CHEBI:35610) |
| (6S)-5-formyltetrahydrofolic acid (CHEBI:63606) has role antineoplastic agent (CHEBI:35610) |
| (9E,11E)-octadecadienoic acid (CHEBI:88464) has role antineoplastic agent (CHEBI:35610) |
| (9Z,11E,13Z)-octadecatrienoic acid (CHEBI:8638) has role antineoplastic agent (CHEBI:35610) |
| all-trans-4-oxoretinol (CHEBI:44597) has role antineoplastic agent (CHEBI:35610) |
| ent-kaur-16-en-19-oic acid (CHEBI:15417) has role antineoplastic agent (CHEBI:35610) |
| epi-silvestrol (CHEBI:66485) has role antineoplastic agent (CHEBI:35610) |
| epi-tulipinolide (CHEBI:10552) has role antineoplastic agent (CHEBI:35610) |
| meso-tetrakis(N-methyl-4-pyridyl)porphine tetrakis(p-toluenesulfonate) (CHEBI:78039) has role antineoplastic agent (CHEBI:35610) |
| meso-tetrakis(N-methyl-4-pyridyl)porphine(4+) (CHEBI:37447) has role antineoplastic agent (CHEBI:35610) |
| N-(2-[(2-aminoethyl)(methyl)amino]-5-{[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino}phenyl)acetamide (CHEBI:143115) has role antineoplastic agent (CHEBI:35610) |
| N-(2-methoxyethyl)-4-{[6-(pyridin-4-yl)quinazolin-2-yl]amino}benzamide (CHEBI:143119) has role antineoplastic agent (CHEBI:35610) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide (CHEBI:91399) has role antineoplastic agent (CHEBI:35610) |
| N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}but-2-ynamide (CHEBI:90180) has role antineoplastic agent (CHEBI:35610) |
| N-desmethylenzalutamide (CHEBI:68538) has role antineoplastic agent (CHEBI:35610) |
| N-ethyl-5'-carboxamidoadenosine (CHEBI:73284) has role antineoplastic agent (CHEBI:35610) |
| N-hydroxy-7-(naphthalen-2-ylthio)heptanamide (CHEBI:94741) has role antineoplastic agent (CHEBI:35610) |
| N-hydroxyguanidine (CHEBI:43089) has role antineoplastic agent (CHEBI:35610) |
| N-oleoyltaurine (CHEBI:146206) has role antineoplastic agent (CHEBI:35610) |
| N-palmitoyl-S-[2,3-bis(palmitoyloxy)propyl]-Cys-Ser-Lys-Lys-Lys-Lys (CHEBI:134411) has role antineoplastic agent (CHEBI:35610) |
| N1,N12-diethylspermine (CHEBI:90282) has role antineoplastic agent (CHEBI:35610) |
| N2-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N2-isopropoxy-D-valinamide (CHEBI:93296) has role antineoplastic agent (CHEBI:35610) |
| N6-(Δ2-isopentenyl)adenosine (CHEBI:62881) has role antineoplastic agent (CHEBI:35610) |
| O-(2-aminoethyl)-L-serine (CHEBI:72341) has role antineoplastic agent (CHEBI:35610) |
| O-(chloroacetylcarbamoyl)fumagillol (CHEBI:90748) has role antineoplastic agent (CHEBI:35610) |
| rac-crizotinib (CHEBI:77563) has role antineoplastic agent (CHEBI:35610) |
| S-allylcysteine (CHEBI:74077) has role antineoplastic agent (CHEBI:35610) |
| Se-methyl-L-selenocysteine (CHEBI:27812) has role antineoplastic agent (CHEBI:35610) |
| Se-methylselenocysteine (CHEBI:9068) has role antineoplastic agent (CHEBI:35610) |
| all-cis-5,8,11,14,17-icosapentaenoic acid (CHEBI:28364) has role antineoplastic agent (CHEBI:35610) |
| all-cis-docosa-4,7,10,13,16,19-hexaenoic acid (CHEBI:28125) has role antineoplastic agent (CHEBI:35610) |
| all-trans-retinoic acid (CHEBI:15367) has role antineoplastic agent (CHEBI:35610) |
| cis-9-nonadecenoic acid (CHEBI:78443) has role antineoplastic agent (CHEBI:35610) |
| myo-inositol hexakisphosphate (CHEBI:17401) has role antineoplastic agent (CHEBI:35610) |
| trans-2-hydroxyisoxypropyl-3-hydroxy-7-isopentene-2,3-dihydrobenzofuran-5-carboxylic acid (CHEBI:66044) has role antineoplastic agent (CHEBI:35610) |
| trans-astringin (CHEBI:2899) has role antineoplastic agent (CHEBI:35610) |
| trans-rhaponticin (CHEBI:8824) has role antineoplastic agent (CHEBI:35610) |
| 223RaCl2 (CHEBI:74895) has role antineoplastic agent (CHEBI:35610) |
| D-glucaric acid (CHEBI:16002) has role antineoplastic agent (CHEBI:35610) |
| L-canaline (CHEBI:41401) has role antineoplastic agent (CHEBI:35610) |
| 1-(2-hydroxy-4-methoxyphenyl)-3-(4-hydroxy-3-methoxyphenyl)propane (CHEBI:69704) has role antineoplastic agent (CHEBI:35610) |
| 1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone (CHEBI:66033) has role antineoplastic agent (CHEBI:35610) |
| 1-O-(α-D-galactosyl)-N-hexacosanoylphytosphingosine (CHEBI:466659) has role antineoplastic agent (CHEBI:35610) |
| 1-O-caffeoylquinic acid (CHEBI:136555) has role antineoplastic agent (CHEBI:35610) |
| 1-behenoylglycerol (CHEBI:142497) has role antineoplastic agent (CHEBI:35610) |
| 1-deoxysphinganine (CHEBI:67106) has role antineoplastic agent (CHEBI:35610) |
| 1-isothiocyanato-6-(methylsulfanyl)hexane (CHEBI:136921) has role antineoplastic agent (CHEBI:35610) |
| 1-methyltryptophan (CHEBI:72821) has role antineoplastic agent (CHEBI:35610) |
| 1,2,3,4,6-pentakis-O-galloyl-β-D-glucose (CHEBI:18082) has role antineoplastic agent (CHEBI:35610) |
| 1,3,6-trihydroxy-2-methyl-9,10-anthraquinone-3-O-(6'-O-acetyl)-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside (CHEBI:69521) has role antineoplastic agent (CHEBI:35610) |
| 1,3,6,8-tetraazatricyclo[6.2.1.13,6]dodecane (CHEBI:63487) has role antineoplastic agent (CHEBI:35610) |
| 1,5,6-trihydroxy-6',6'-dimethyl-2H-pyrano(2',3':3,4)-2-(3-methylbut-2-enyl)xanthone (CHEBI:66792) has role antineoplastic agent (CHEBI:35610) |
| 1,6,7-trihydroxy-6',6'-dimethyl-2H-pyrano(2',3':3,2)-4-(3-methylbut-2-enyl)xanthone (CHEBI:66793) has role antineoplastic agent (CHEBI:35610) |
| 1'-acetoxychavicol acetate (CHEBI:469) has role antineoplastic agent (CHEBI:35610) |
| 1R,4S,6R-1,4-endoperoxy-bisabola-2,10-diene (CHEBI:65845) has role antineoplastic agent (CHEBI:35610) |
| 1S,4R,6R-1,4-endoperoxy-bisabola-2,10-diene (CHEBI:65844) has role antineoplastic agent (CHEBI:35610) |
| 1S,6R-di(2-)methylbutanoyloxy-4S-hydroxy-8S-benzoyloxy-9R-(3-)furancarbonyloxy-13-acetyloxy-β-dihydroagarofuran (CHEBI:65878) has role antineoplastic agent (CHEBI:35610) |
| 10-hydroxycanthin-6-one (CHEBI:66064) has role antineoplastic agent (CHEBI:35610) |
| 10058-F4 (CHEBI:149696) has role antineoplastic agent (CHEBI:35610) |
| 12-O-acetyl-16-O-deacetyl-16-epi-scalarobutenolide (CHEBI:65366) has role antineoplastic agent (CHEBI:35610) |
| 12-deacetoxy-21-acetoxyscalarin (CHEBI:66063) has role antineoplastic agent (CHEBI:35610) |
| 12-ketomethymycin (CHEBI:188461) has role antineoplastic agent (CHEBI:35610) |
| 13-deoxycarminomycin (CHEBI:31056) has role antineoplastic agent (CHEBI:35610) |
| 13,14-dihydro-Δ12-prostaglandin J2 (CHEBI:28130) has role antineoplastic agent (CHEBI:35610) |
| 13(S)-HODE (CHEBI:34154) has role antineoplastic agent (CHEBI:35610) |
| 14-norpseurotin A (CHEBI:66636) has role antineoplastic agent (CHEBI:35610) |
| 15-O-deacetylnimbolidin B (CHEBI:65725) has role antineoplastic agent (CHEBI:35610) |
| 16-O-deacetyl-16-epi-scalarolbutenolide (CHEBI:66061) has role antineoplastic agent (CHEBI:35610) |
| 16,23-epoxy-5β-cholestane triglycoside (CHEBI:65855) has role antineoplastic agent (CHEBI:35610) |
| 16β-[(O-(2-O-(E)-cinnamoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65629) has role antineoplastic agent (CHEBI:35610) |
| 16β-[(α-L-arabinopyranosyl)oxy]-3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxycholest-5-en-22-one (CHEBI:65628) has role antineoplastic agent (CHEBI:35610) |
| 17-epi-17-hydroxyazadiradione (CHEBI:67288) has role antineoplastic agent (CHEBI:35610) |
| 17α-ethynylestradiol 3-sulfate (CHEBI:136600) has role antineoplastic agent (CHEBI:35610) |
| 17α-hydroxywithanolide D (CHEBI:66329) has role antineoplastic agent (CHEBI:35610) |
| 18-oxotryprostatin A (CHEBI:66842) has role antineoplastic agent (CHEBI:35610) |
| 2-(2,4-dihydroxy-5-prenylphenyl)-5,6-methylenedioxybenzofuran (CHEBI:65785) has role antineoplastic agent (CHEBI:35610) |
| 2-(6-methoxy-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-[4-(piperazin-1-yl)pyridin-3-yl]-1,3-thiazole-4-carboxamide (CHEBI:90627) has role antineoplastic agent (CHEBI:35610) |
| 2-(7-aminoheptyl)guanidine (CHEBI:133366) has role antineoplastic agent (CHEBI:35610) |
| 2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide (CHEBI:177298) has role antineoplastic agent (CHEBI:35610) |
| 2-{4-[(3R)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (CHEBI:177299) has role antineoplastic agent (CHEBI:35610) |
| 2-acetamidophenol (CHEBI:143107) has role antineoplastic agent (CHEBI:35610) |
| 2-amino-3-cyano-7-(dimethylamino)-4-(2-methoxyphenyl)-4H-chromene (CHEBI:194427) has role antineoplastic agent (CHEBI:35610) |
| 2-amino-4-(3-nitrophenyl)-3-cyano-7-(dimethylamino)-4H-chromene (CHEBI:192743) has role antineoplastic agent (CHEBI:35610) |
| 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoic acid (CHEBI:73307) has role antineoplastic agent (CHEBI:35610) |
| 2-fluoroadenine (CHEBI:72457) has role antineoplastic agent (CHEBI:35610) |
| 2-heptylfuran (CHEBI:167091) has role antineoplastic agent (CHEBI:35610) |
| 2-hydroxylinoleic acid (CHEBI:136927) has role antineoplastic agent (CHEBI:35610) |
| 2-hydroxymelatonin (CHEBI:145792) has role antineoplastic agent (CHEBI:35610) |
| 2-hydroxyoleic acid (CHEBI:143096) has role antineoplastic agent (CHEBI:35610) |
| 2-methoxy-17β-estradiol (CHEBI:28955) has role antineoplastic agent (CHEBI:35610) |
| 2,3-dihydro-3β-O-sulfate withaferin A (CHEBI:69123) has role antineoplastic agent (CHEBI:35610) |
| 2,4,4',6-tetrahydroxydibenzoylmethane (CHEBI:75418) has role antineoplastic agent (CHEBI:35610) |
| 2,5-bis(2-hydroxyethylamino)-3,6-diaziridinylbenzoquinone (CHEBI:90193) has role antineoplastic agent (CHEBI:35610) |
| 2,5-epoxy-2β-hydroxy-8α-(2-methylbut-2-enoyloxy)-4(15),10(14),11(13)-germacratrien-12,6α-olide (CHEBI:65834) has role antineoplastic agent (CHEBI:35610) |
| 2',4'-dihydroxy-3'-(2-hydroxy benzyl)-6'-methoxy chalcone (CHEBI:65777) has role antineoplastic agent (CHEBI:35610) |
| 20-epi-bryonolic acid (CHEBI:65846) has role antineoplastic agent (CHEBI:35610) |
| 20-hydroxytubocapsanolide A (CHEBI:66326) has role antineoplastic agent (CHEBI:35610) |
| 20(R),22(ξ),24(S)-dammar-25(26)-ene-3β,6α,12β,20,22,24-hexanol (CHEBI:65722) has role antineoplastic agent (CHEBI:35610) |
| 23-hydroxytubocapsanolide A (CHEBI:66327) has role antineoplastic agent (CHEBI:35610) |
| 23,24-dimethylcholest-16(17)-E-en-3β,5α,6β,20(S)-tetrol (CHEBI:66175) has role antineoplastic agent (CHEBI:35610) |
| 25-O-methoxycimigenol 3-O-α-L-arabinopyranoside (CHEBI:66702) has role antineoplastic agent (CHEBI:35610) |
| 28-deoxonimbolide (CHEBI:67307) has role antineoplastic agent (CHEBI:35610) |
| 2α-(2'-pyrrolyl)-4α-methoxycarbonyl-5β-[(2''-methyl)-heptyl]-1,3-oxazacyclohexane (CHEBI:65617) has role antineoplastic agent (CHEBI:35610) |
| 2α-(3-hydroxypropyl)-1α,25-dihydroxy-19-norvitamin D3 (CHEBI:91006) has role antineoplastic agent (CHEBI:35610) |
| 2β-methoxy-2-deethoxy-8-O-deacylphantomolin-8-O-tiglinate (CHEBI:65836) has role antineoplastic agent (CHEBI:35610) |
| 2β-methoxy-2-deethoxyphantomolin (CHEBI:65835) has role antineoplastic agent (CHEBI:35610) |
| 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid (CHEBI:75390) has role antineoplastic agent (CHEBI:35610) |
| 3-epi-heliangin (CHEBI:65881) has role antineoplastic agent (CHEBI:35610) |
| 3-O-feruloylcycloartenol (CHEBI:69436) has role antineoplastic agent (CHEBI:35610) |
| 3-acetamino-6-isobutyl-2,5-dioxopiperazine (CHEBI:65362) has role antineoplastic agent (CHEBI:35610) |
| 3-bromopyruvic acid (CHEBI:131461) has role antineoplastic agent (CHEBI:35610) |
| 3-hydroxy-2-hydroxymethyl-9,10-anthraquinone (CHEBI:69520) has role antineoplastic agent (CHEBI:35610) |
| 3-iodo-L-phenylalanine (CHEBI:233132) has role antineoplastic agent (CHEBI:35610) |
| 3-β-O-(E)-coumaroyl-D:C-friedooleana-7,9(11)-dien-29-oic acid (CHEBI:65663) has role antineoplastic agent (CHEBI:35610) |
| 3,3'-diindolylmethane (CHEBI:50182) has role antineoplastic agent (CHEBI:35610) |
| 3,3'-dimethylquercetin (CHEBI:146138) has role antineoplastic agent (CHEBI:35610) |
| 3,4-dihydroxybenzoic acid (CHEBI:36062) has role antineoplastic agent (CHEBI:35610) |
| 3,4'-dimethylkaempferol (CHEBI:146142) has role antineoplastic agent (CHEBI:35610) |
| 3,5-di-O-caffeoyl quinic acid (CHEBI:65751) has role antineoplastic agent (CHEBI:35610) |
| 3,5-dihydroxy-2-(1'-oxo-3'-hexadecenyl)-2-cyclohexene-1-one (CHEBI:65773) has role antineoplastic agent (CHEBI:35610) |
| 3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-β-D-glucopyranoside (CHEBI:68338) has role antineoplastic agent (CHEBI:35610) |
| 3,7-dihydroxytropolone (CHEBI:156362) has role antineoplastic agent (CHEBI:35610) |
| 3'-deamino-3'-(3-cyanomorpholin-4-yl)doxorubicin (CHEBI:41576) has role antineoplastic agent (CHEBI:35610) |
| 3',4'-difluoro-N-{4'-fluoro-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-yl}-6-[(3S)-pyrrolidin-3-yloxy][biphenyl]-3-carboxamide (CHEBI:147294) has role antineoplastic agent (CHEBI:35610) |
| 3',4',5-trihydroxy-3,6,7-trimethoxyflavone (CHEBI:18016) has role antineoplastic agent (CHEBI:35610) |
| 3',4',7-trihydroxyisoflavone (CHEBI:50399) has role antineoplastic agent (CHEBI:35610) |
| 3PO (CHEBI:144367) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→3)-4,6-dideoxy-2-O-methyl-β-D-gulopyranosyl)]-5β,14β-dihydroxy-19-oxocard-20(22)enolide (CHEBI:65677) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65625) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4,5-trimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65626) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17αhydroxy-16β-[(O-(3-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65627) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65623) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4,5-trimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65624) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65621) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4,5-trimethoxybenzoyl-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one (CHEBI:65620) has role antineoplastic agent (CHEBI:35610) |
| 3β-[(β-D-glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-β-D-xylopyranosyl)-(1→3)-2-O-acetyl-α-L-arabinopyranosyloxy]cholest-5-en-22-one (CHEBI:65622) has role antineoplastic agent (CHEBI:35610) |
| 3β-O-{α-L-Rhap-(1→2)-β-D-Glcp-(1→4)-[β-D-Glcp-(1→2)]-α-L-Arap}primulagenin A (CHEBI:65424) has role antineoplastic agent (CHEBI:35610) |
| 3β,12-dihydroxy-13-methyl-5,8,11,13-podocarpatetraene-7-one (CHEBI:65781) has role antineoplastic agent (CHEBI:35610) |
| 3β,12-dihydroxy-13-methyl-6,8,11,13-podocarpatetraene (CHEBI:65782) has role antineoplastic agent (CHEBI:35610) |
| 4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide (CHEBI:91326) has role antineoplastic agent (CHEBI:35610) |
| 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide (CHEBI:125562) has role antineoplastic agent (CHEBI:35610) |
| 4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid (CHEBI:64210) has role antineoplastic agent (CHEBI:35610) |
| 4-amino-TEMPO (CHEBI:180672) has role antineoplastic agent (CHEBI:35610) |
| 4-hydroperoxycyclophosphamide (CHEBI:196991) has role antineoplastic agent (CHEBI:35610) |
| 4-hydroxy-TEMPO (CHEBI:180664) has role antineoplastic agent (CHEBI:35610) |
| 4-hydroxyphenyl retinamide (CHEBI:42588) has role antineoplastic agent (CHEBI:35610) |
| 4-iodo-6-phenylpyrimidine (CHEBI:91213) has role antineoplastic agent (CHEBI:35610) |
| 4-methoxymagnaldehyde B (CHEBI:66705) has role antineoplastic agent (CHEBI:35610) |
| 4-methyl-5-pentylbenzene-1,3-diol (CHEBI:61089) has role antineoplastic agent (CHEBI:35610) |
| 4-methylaeruginoic acid (CHEBI:66368) has role antineoplastic agent (CHEBI:35610) |
| 4-methylumbelliferone (CHEBI:17224) has role antineoplastic agent (CHEBI:35610) |
| 4-methylumbelliferone β-D-glucuronide (CHEBI:1904) has role antineoplastic agent (CHEBI:35610) |
| 4-phenylbutyric acid (CHEBI:41500) has role antineoplastic agent (CHEBI:35610) |
| 4-terpineol (CHEBI:78884) has role antineoplastic agent (CHEBI:35610) |
| 4,5,4'-trihydroxy-3,3'-dimethoxybibenzyl (CHEBI:193138) has role antineoplastic agent (CHEBI:35610) |
| 4'-demethyldeoxypodophyllotoxin (CHEBI:1729) has role antineoplastic agent (CHEBI:35610) |
| 4'-demethylepipodophyllotoxin (CHEBI:74422) has role antineoplastic agent (CHEBI:35610) |
| 4'-epidoxorubicin (CHEBI:47898) has role antineoplastic agent (CHEBI:35610) |
| 4'-hydroxychalcone (CHEBI:34360) has role antineoplastic agent (CHEBI:35610) |
| 4',5,7-trihydroxy-3'-methoxyflavone (CHEBI:16514) has role antineoplastic agent (CHEBI:35610) |
| 4',5'-dihydro-11,5'-dihydroxy-4'-methoxytephrosin (CHEBI:65772) has role antineoplastic agent (CHEBI:35610) |
| 4''-dehydro-3-hydroxyterphenyllin (CHEBI:67529) has role antineoplastic agent (CHEBI:35610) |
| 5-(N,N-hexamethylene)amiloride (CHEBI:76400) has role antineoplastic agent (CHEBI:35610) |
| 5-(2,2-diferuloylethen-1-yl)thalidomide (CHEBI:74775) has role antineoplastic agent (CHEBI:35610) |
| 5-(tetradecyloxy)-2-furoic acid (CHEBI:77936) has role antineoplastic agent (CHEBI:35610) |
| 5-[2-(feruloyl)ethen-1-yl]thalidomide (CHEBI:74774) has role antineoplastic agent (CHEBI:35610) |
| 5-O-ethyl embelin (CHEBI:65843) has role antineoplastic agent (CHEBI:35610) |
| 5-O-methyl embelin (CHEBI:65842) has role antineoplastic agent (CHEBI:35610) |
| 5-aminolevulinic acid (CHEBI:17549) has role antineoplastic agent (CHEBI:35610) |
| 5-aminolevulinic acid hydrochloride (CHEBI:132969) has role antineoplastic agent (CHEBI:35610) |
| 5-azacytidine (CHEBI:2038) has role antineoplastic agent (CHEBI:35610) |
| 5-bromo-2'-deoxyuridine (CHEBI:472552) has role antineoplastic agent (CHEBI:35610) |
| 5-bromo-8-methoxy-1-methyl-β-carboline (CHEBI:65524) has role antineoplastic agent (CHEBI:35610) |
| 5-chloro-7-iodoquinolin-8-ol (CHEBI:74460) has role antineoplastic agent (CHEBI:35610) |
| 5-fluorouracil (CHEBI:46345) has role antineoplastic agent (CHEBI:35610) |
| 5-heptadecylresorcinol (CHEBI:145967) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-2-(1'-hydroxyethyl)naphtho[2,3-b]furan-4,9-dione (CHEBI:66028) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-2-methylchromone-7-O-rutinoside (CHEBI:66371) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-6-methoxy-2-methylchromone-7-O-rutinoside (CHEBI:66370) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-7-prop-2-en-(E)-ylidene-7,7a-dihydro- 2H-cyclopenta[b]pyran-6-one (CHEBI:65800) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxy-7-prop-2-en-(Z)-ylidene-7,7a-dihydro- 2H-cyclopenta[b]pyran-6-one (CHEBI:65801) has role antineoplastic agent (CHEBI:35610) |
| 5-hydroxyimidazole-4-carboxamide (CHEBI:88290) has role antineoplastic agent (CHEBI:35610) |
| 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole (CHEBI:49852) has role antineoplastic agent (CHEBI:35610) |
| 5,6-epoxyretinoic acid (CHEBI:80658) has role antineoplastic agent (CHEBI:35610) |
| 5,7,3'-trihydroxy-4'-methoxy-8,2'-di(3-methyl-2-butenyl)-(2S)-flavanone (CHEBI:66264) has role antineoplastic agent (CHEBI:35610) |
| 5E-7-oxozeaenol (CHEBI:67558) has role antineoplastic agent (CHEBI:35610) |
| 5Z-7-oxozeaenol (CHEBI:67559) has role antineoplastic agent (CHEBI:35610) |
| 5α,8α-epidioxycholest-6-en-3β-ol (CHEBI:65851) has role antineoplastic agent (CHEBI:35610) |
| 5α,8α-epidioxysterol (CHEBI:65853) has role antineoplastic agent (CHEBI:35610) |
| 6-[1'-oxo-3'(R)-hydroxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (CHEBI:66660) has role antineoplastic agent (CHEBI:35610) |
| 6-[1'-oxo-3'(R)-methoxy-butyl]-5,7-dimethoxy-2,2-dimethyl-2H-1-benzopyran (CHEBI:66661) has role antineoplastic agent (CHEBI:35610) |
| 6-anilino-5,8-quinolinedione (CHEBI:78677) has role antineoplastic agent (CHEBI:35610) |
| 6-azauridine (CHEBI:35668) has role antineoplastic agent (CHEBI:35610) |
| 6-azauridine 5'-monophosphate (CHEBI:46319) has role antineoplastic agent (CHEBI:35610) |
| 6-azauridine 5'-monophosphate(2−) (CHEBI:147401) has role antineoplastic agent (CHEBI:35610) |
| 6-chloro-7-[2-(4-morpholinyl)ethylamino]quinoline-5,8-dione (CHEBI:92053) has role antineoplastic agent (CHEBI:35610) |
| 6-diazo-5-oxo-L-norleucine (CHEBI:138889) has role antineoplastic agent (CHEBI:35610) |
| 6-hydroxypaclitaxel (CHEBI:63859) has role antineoplastic agent (CHEBI:35610) |
| 6-methoxyspirotryprostatin B (CHEBI:66707) has role antineoplastic agent (CHEBI:35610) |
| 6'-O-galloylalbiflorin (CHEBI:132816) has role antineoplastic agent (CHEBI:35610) |
| 7-(4''-hydroxy-3''-methoxyphenyl)-1-phenyl-4E-heptene-3-one (CHEBI:66034) has role antineoplastic agent (CHEBI:35610) |
| 7-(4''-hydroxy-3''-methoxyphenyl)-5-methoxy-1-phenyl-3-heptanone (CHEBI:66032) has role antineoplastic agent (CHEBI:35610) |
| 7-deacetyl-7-benzoylgedunin (CHEBI:67297) has role antineoplastic agent (CHEBI:35610) |
| 7-methoxydeoxymorellin (CHEBI:66704) has role antineoplastic agent (CHEBI:35610) |
| 7-nor-ergosterolide (CHEBI:70332) has role antineoplastic agent (CHEBI:35610) |
| 7-oxo-3,8,9-trihydroxy staurosporine (CHEBI:66839) has role antineoplastic agent (CHEBI:35610) |
| 7-oxo-8,9-dihydroxy-4'-N-demethyl staurosporine (CHEBI:66840) has role antineoplastic agent (CHEBI:35610) |
| 7,3',4'-trihydroxy-3,8-dimethoxyflavone (CHEBI:69452) has role antineoplastic agent (CHEBI:35610) |
| 7,8-dehydrocerberin (CHEBI:65734) has role antineoplastic agent (CHEBI:35610) |
| 7,8-dihydroxyflavanone (CHEBI:65787) has role antineoplastic agent (CHEBI:35610) |
| 7,8-dihydroxyflavone (CHEBI:140464) has role antineoplastic agent (CHEBI:35610) |
| 7α-hydroperoxy manool (CHEBI:66025) has role antineoplastic agent (CHEBI:35610) |
| 8-(2-chloro-3,4,5-trimethoxybenzyl)-2-fluoro-9-pent-4-yn-1-yl-9H-purin-6-amine (CHEBI:47628) has role antineoplastic agent (CHEBI:35610) |
| 8-acetoxy-4,10-dihydroxy-2,11(13)-guaiadiene-12,6-olide (CHEBI:65363) has role antineoplastic agent (CHEBI:35610) |
| 8-azaguanine (CHEBI:63486) has role antineoplastic agent (CHEBI:35610) |
| 8-hydroxy-2-(1'-hydroxyethyl)naphtho-[2,3-b]-furan-4,9-dione (CHEBI:66029) has role antineoplastic agent (CHEBI:35610) |
| 8-PIP-cAMP (CHEBI:145730) has role antineoplastic agent (CHEBI:35610) |
| 8,8a-epoxymorellic acid (CHEBI:66402) has role antineoplastic agent (CHEBI:35610) |
| 9-cis-retinoate (CHEBI:78630) has role antineoplastic agent (CHEBI:35610) |
| 9-cis-retinoic acid (CHEBI:50648) has role antineoplastic agent (CHEBI:35610) |
| 9-deacetoxyfumigaclavine C (CHEBI:65724) has role antineoplastic agent (CHEBI:35610) |
| 9-hydroxy hedychenone (CHEBI:66010) has role antineoplastic agent (CHEBI:35610) |
| 9-hydroxycanthin-6-one (CHEBI:66041) has role antineoplastic agent (CHEBI:35610) |
| 9-hydroxyellipticine (CHEBI:88297) has role antineoplastic agent (CHEBI:35610) |
| 9-methoxycanthin-6-one (CHEBI:66699) has role antineoplastic agent (CHEBI:35610) |
| 9-β-D-arabinofuranosylguanine (CHEBI:73141) has role antineoplastic agent (CHEBI:35610) |
| 9(11)-dehydroaxinysterol (CHEBI:65733) has role antineoplastic agent (CHEBI:35610) |
| 9H-purine-2,6-diamine (CHEBI:40235) has role antineoplastic agent (CHEBI:35610) |
| 9α,11α-dihydroxyergosta-4,6,8(14),22-tetraen-3-one (CHEBI:68054) has role antineoplastic agent (CHEBI:35610) |
| A2-32-01 (CHEBI:86341) has role antineoplastic agent (CHEBI:35610) |
| A2-58-06 (CHEBI:86342) has role antineoplastic agent (CHEBI:35610) |
| abarelix (CHEBI:337298) has role antineoplastic agent (CHEBI:35610) |
| abexinostat (CHEBI:92223) has role antineoplastic agent (CHEBI:35610) |
| abiraterone (CHEBI:68642) has role antineoplastic agent (CHEBI:35610) |
| abiraterone acetate (CHEBI:68639) has role antineoplastic agent (CHEBI:35610) |
| ABT-737 (CHEBI:47575) has role antineoplastic agent (CHEBI:35610) |
| abyssinone A (CHEBI:65358) has role antineoplastic agent (CHEBI:35610) |
| abyssinone C (CHEBI:65359) has role antineoplastic agent (CHEBI:35610) |
| abyssinone D (CHEBI:65360) has role antineoplastic agent (CHEBI:35610) |
| acadesine (CHEBI:28498) has role antineoplastic agent (CHEBI:35610) |
| acalabrutinib (CHEBI:167707) has role antineoplastic agent (CHEBI:35610) |
| acetyl aleuritolic acid (CHEBI:70418) has role antineoplastic agent (CHEBI:35610) |
| acivicin (CHEBI:74545) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin A (CHEBI:74619) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin A zwitterion (CHEBI:77980) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin N (CHEBI:75091) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin S (CHEBI:79176) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin S zwitterion (CHEBI:78303) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin T (CHEBI:74351) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin T hydrochloride (CHEBI:74758) has role antineoplastic agent (CHEBI:35610) |
| aclacinomycin T zwitterion (CHEBI:77979) has role antineoplastic agent (CHEBI:35610) |
| acriflavinium chloride (CHEBI:74728) has role antineoplastic agent (CHEBI:35610) |
| acronycine (CHEBI:2437) has role antineoplastic agent (CHEBI:35610) |
| actinodaphnine (CHEBI:2444) has role antineoplastic agent (CHEBI:35610) |
| aculeatol E (CHEBI:65368) has role antineoplastic agent (CHEBI:35610) |
| acumitin (CHEBI:65369) has role antineoplastic agent (CHEBI:35610) |
| adavosertib (CHEBI:91414) has role antineoplastic agent (CHEBI:35610) |
| adenine arabinoside (CHEBI:45327) has role antineoplastic agent (CHEBI:35610) |
| adonixanthin (CHEBI:80217) has role antineoplastic agent (CHEBI:35610) |
| AEE788 (CHEBI:40629) has role antineoplastic agent (CHEBI:35610) |
| afatinib (CHEBI:61390) has role antineoplastic agent (CHEBI:35610) |
| afatinib dimaleate (CHEBI:76003) has role antineoplastic agent (CHEBI:35610) |
| afimoxifene (CHEBI:44616) has role antineoplastic agent (CHEBI:35610) |
| agathisflavone (CHEBI:2512) has role antineoplastic agent (CHEBI:35610) |
| ageladine A (CHEBI:65373) has role antineoplastic agent (CHEBI:35610) |
| agigenin (CHEBI:72849) has role antineoplastic agent (CHEBI:35610) |
| aglaiabbreviatin F (CHEBI:70267) has role antineoplastic agent (CHEBI:35610) |
| akebia saponin D (CHEBI:194124) has role antineoplastic agent (CHEBI:35610) |
| AKI00000020a (CHEBI:169940) has role antineoplastic agent (CHEBI:35610) |
| aklavinone (CHEBI:31181) has role antineoplastic agent (CHEBI:35610) |
| alantolactone (CHEBI:2540) has role antineoplastic agent (CHEBI:35610) |
| alatolide (CHEBI:2542) has role antineoplastic agent (CHEBI:35610) |
| albizoside A (CHEBI:65379) has role antineoplastic agent (CHEBI:35610) |
| albizoside B (CHEBI:65380) has role antineoplastic agent (CHEBI:35610) |
| albizoside C (CHEBI:65381) has role antineoplastic agent (CHEBI:35610) |
| alectinib (CHEBI:90936) has role antineoplastic agent (CHEBI:35610) |
| alectinib hydrochloride (CHEBI:62268) has role antineoplastic agent (CHEBI:35610) |
| alfuzosin (CHEBI:51141) has role antineoplastic agent (CHEBI:35610) |
| alisertib (CHEBI:125628) has role antineoplastic agent (CHEBI:35610) |
| allanxanthone C (CHEBI:65387) has role antineoplastic agent (CHEBI:35610) |
| allyl isothiocyanate (CHEBI:73224) has role antineoplastic agent (CHEBI:35610) |
| Aloe emodin (CHEBI:2607) has role antineoplastic agent (CHEBI:35610) |
| alsterpaullone (CHEBI:138488) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin E (CHEBI:65390) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin F (CHEBI:65391) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin G (CHEBI:65392) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin H (CHEBI:65393) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin I (CHEBI:65394) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin J (CHEBI:65395) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin K (CHEBI:65396) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin L (CHEBI:65397) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin M (CHEBI:65398) has role antineoplastic agent (CHEBI:35610) |
| alvaradoin N (CHEBI:65399) has role antineoplastic agent (CHEBI:35610) |
| alvocidib (CHEBI:47344) has role antineoplastic agent (CHEBI:35610) |
| alvocidib hydrochloride (CHEBI:90998) has role antineoplastic agent (CHEBI:35610) |
| AM-251 (CHEBI:90724) has role antineoplastic agent (CHEBI:35610) |
| AMG-208 (CHEBI:90626) has role antineoplastic agent (CHEBI:35610) |
| AMG-925 (CHEBI:145537) has role antineoplastic agent (CHEBI:35610) |
| aminoglutethimide (CHEBI:2654) has role antineoplastic agent (CHEBI:35610) |
| amomol A (CHEBI:65404) has role antineoplastic agent (CHEBI:35610) |
| amrubicin (CHEBI:135779) has role antineoplastic agent (CHEBI:35610) |
| amrubicinol (CHEBI:156204) has role antineoplastic agent (CHEBI:35610) |
| amsacrine (CHEBI:2687) has role antineoplastic agent (CHEBI:35610) |
| anastrozole (CHEBI:2704) has role antineoplastic agent (CHEBI:35610) |
| ancitabine (CHEBI:74838) has role antineoplastic agent (CHEBI:35610) |
| ancitabine hydrochloride (CHEBI:74843) has role antineoplastic agent (CHEBI:35610) |
| andrographolide (CHEBI:65408) has role antineoplastic agent (CHEBI:35610) |
| ansamitocin P3 (CHEBI:29515) has role antineoplastic agent (CHEBI:35610) |
| anthra[1,9-cd]pyrazol-6(2H)-one (CHEBI:90695) has role antineoplastic agent (CHEBI:35610) |
| anthramycin (CHEBI:40699) has role antineoplastic agent (CHEBI:35610) |
| antroquinonol (CHEBI:65415) has role antineoplastic agent (CHEBI:35610) |
| AOH1996 (CHEBI:195529) has role antineoplastic agent (CHEBI:35610) |
| aphidicolin (CHEBI:2766) has role antineoplastic agent (CHEBI:35610) |
| apigenin (CHEBI:18388) has role antineoplastic agent (CHEBI:35610) |
| aplysinoplide A (CHEBI:65418) has role antineoplastic agent (CHEBI:35610) |
| aplysinoplide B (CHEBI:65419) has role antineoplastic agent (CHEBI:35610) |
| aplysinoplide C (CHEBI:65420) has role antineoplastic agent (CHEBI:35610) |
| apratoxin A (CHEBI:35212) has role antineoplastic agent (CHEBI:35610) |
| apratoxin D (CHEBI:65421) has role antineoplastic agent (CHEBI:35610) |
| apratoxin E (CHEBI:65422) has role antineoplastic agent (CHEBI:35610) |
| AR-42 (CHEBI:188197) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside A (CHEBI:65425) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside B (CHEBI:65426) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside C (CHEBI:65427) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside D (CHEBI:65428) has role antineoplastic agent (CHEBI:35610) |
| ardisianoside E (CHEBI:65429) has role antineoplastic agent (CHEBI:35610) |
| ardisiphenol A (CHEBI:65430) has role antineoplastic agent (CHEBI:35610) |
| ardisiphenol B (CHEBI:65431) has role antineoplastic agent (CHEBI:35610) |
| ardisiphenol C (CHEBI:65432) has role antineoplastic agent (CHEBI:35610) |
| arenamide A (CHEBI:65433) has role antineoplastic agent (CHEBI:35610) |
| arenamide B (CHEBI:65434) has role antineoplastic agent (CHEBI:35610) |
| arglabin (CHEBI:73228) has role antineoplastic agent (CHEBI:35610) |
| arotinoid acid (CHEBI:75261) has role antineoplastic agent (CHEBI:35610) |
| ARS-1620 (CHEBI:193597) has role antineoplastic agent (CHEBI:35610) |
| artesunate (CHEBI:63918) has role antineoplastic agent (CHEBI:35610) |
| artocarpin (CHEBI:65439) has role antineoplastic agent (CHEBI:35610) |
| artochamin C (CHEBI:65440) has role antineoplastic agent (CHEBI:35610) |
| artoindonesianin E1 (CHEBI:65441) has role antineoplastic agent (CHEBI:35610) |
| artoindonesianin P (CHEBI:65442) has role antineoplastic agent (CHEBI:35610) |
| AS-I-145 (CHEBI:82669) has role antineoplastic agent (CHEBI:35610) |
| AS1842856 (CHEBI:145800) has role antineoplastic agent (CHEBI:35610) |
| ascochlorin (CHEBI:156219) has role antineoplastic agent (CHEBI:35610) |
| ascofuranone (CHEBI:156148) has role antineoplastic agent (CHEBI:35610) |
| asiaticoside (CHEBI:79928) has role antineoplastic agent (CHEBI:35610) |
| ASP-3026 (CHEBI:167650) has role antineoplastic agent (CHEBI:35610) |
| asperfuranone (CHEBI:64397) has role antineoplastic agent (CHEBI:35610) |
| aspergillide A (CHEBI:65450) has role antineoplastic agent (CHEBI:35610) |
| aspergillide B (CHEBI:65451) has role antineoplastic agent (CHEBI:35610) |
| aspergillide C (CHEBI:65452) has role antineoplastic agent (CHEBI:35610) |
| asperphenamate (CHEBI:145105) has role antineoplastic agent (CHEBI:35610) |
| asprellic acid A (CHEBI:65455) has role antineoplastic agent (CHEBI:35610) |
| asprellic acid C (CHEBI:65456) has role antineoplastic agent (CHEBI:35610) |
| asukamycin (CHEBI:73481) has role antineoplastic agent (CHEBI:35610) |
| AT7867 (CHEBI:82708) has role antineoplastic agent (CHEBI:35610) |
| atromentin (CHEBI:149660) has role antineoplastic agent (CHEBI:35610) |
| auraptene (CHEBI:134355) has role antineoplastic agent (CHEBI:35610) |
| aureothin (CHEBI:80024) has role antineoplastic agent (CHEBI:35610) |
| austocystin D (CHEBI:67827) has role antineoplastic agent (CHEBI:35610) |
| avenanthramide B (CHEBI:167489) has role antineoplastic agent (CHEBI:35610) |
| axitinib (CHEBI:66910) has role antineoplastic agent (CHEBI:35610) |
| AZ505 (CHEBI:228259) has role antineoplastic agent (CHEBI:35610) |
| azadirone (CHEBI:76293) has role antineoplastic agent (CHEBI:35610) |
| azaserine (CHEBI:74846) has role antineoplastic agent (CHEBI:35610) |
| azathioprine (CHEBI:2948) has role antineoplastic agent (CHEBI:35610) |
| AZD-1152 (CHEBI:91367) has role antineoplastic agent (CHEBI:35610) |
| AZD-8055 (CHEBI:91329) has role antineoplastic agent (CHEBI:35610) |
| AZD-8835 (CHEBI:234357) has role antineoplastic agent (CHEBI:35610) |
| AZD1080 (CHEBI:167651) has role antineoplastic agent (CHEBI:35610) |
| AZD2858 (CHEBI:167652) has role antineoplastic agent (CHEBI:35610) |
| AZD3463 (CHEBI:167653) has role antineoplastic agent (CHEBI:35610) |
| AZD3965 (CHEBI:234329) has role antineoplastic agent (CHEBI:35610) |
| AZD5153 (CHEBI:231674) has role antineoplastic agent (CHEBI:35610) |
| AZD7762 (CHEBI:131156) has role antineoplastic agent (CHEBI:35610) |
| AZD8186 (CHEBI:234358) has role antineoplastic agent (CHEBI:35610) |
| AZT-1152 (CHEBI:167636) has role antineoplastic agent (CHEBI:35610) |
| b-AP15 (CHEBI:229606) has role antineoplastic agent (CHEBI:35610) |
| baicalein (CHEBI:2979) has role antineoplastic agent (CHEBI:35610) |
| baicalin (CHEBI:2981) has role antineoplastic agent (CHEBI:35610) |
| BAM15 (CHEBI:233585) has role antineoplastic agent (CHEBI:35610) |
| bassianolide (CHEBI:145108) has role antineoplastic agent (CHEBI:35610) |
| batimastat (CHEBI:195398) has role antineoplastic agent (CHEBI:35610) |
| BAY-826 (CHEBI:192483) has role antineoplastic agent (CHEBI:35610) |
| BAY11-7085 (CHEBI:176500) has role antineoplastic agent (CHEBI:35610) |
| BCI-215 (CHEBI:143128) has role antineoplastic agent (CHEBI:35610) |
| BDA-366 (CHEBI:86325) has role antineoplastic agent (CHEBI:35610) |
| BE-54238A (CHEBI:65475) has role antineoplastic agent (CHEBI:35610) |
| BE-54238B (CHEBI:65476) has role antineoplastic agent (CHEBI:35610) |
| beauvericin (CHEBI:3000) has role antineoplastic agent (CHEBI:35610) |
| belinostat (CHEBI:61076) has role antineoplastic agent (CHEBI:35610) |
| berberine (CHEBI:16118) has role antineoplastic agent (CHEBI:35610) |
| berkeleydione (CHEBI:69021) has role antineoplastic agent (CHEBI:35610) |
| betulin (CHEBI:3086) has role antineoplastic agent (CHEBI:35610) |
| betulinic acid (CHEBI:3087) has role antineoplastic agent (CHEBI:35610) |
| bexarotene (CHEBI:50859) has role antineoplastic agent (CHEBI:35610) |
| BF 4 (CHEBI:65488) has role antineoplastic agent (CHEBI:35610) |
| BF 5 (CHEBI:65489) has role antineoplastic agent (CHEBI:35610) |
| BF 6 (CHEBI:65490) has role antineoplastic agent (CHEBI:35610) |
| BGJ-398 (CHEBI:63451) has role antineoplastic agent (CHEBI:35610) |
| BGT226 (CHEBI:71953) has role antineoplastic agent (CHEBI:35610) |
| BGT226 free base (CHEBI:71967) has role antineoplastic agent (CHEBI:35610) |
| BI-2536 (CHEBI:49868) has role antineoplastic agent (CHEBI:35610) |
| BI-3406 (CHEBI:746963) has role antineoplastic agent (CHEBI:35610) |
| BI-4020 (CHEBI:232716) has role antineoplastic agent (CHEBI:35610) |
| bianfugenine (CHEBI:132719) has role antineoplastic agent (CHEBI:35610) |
| bicalutamide (CHEBI:3090) has role antineoplastic agent (CHEBI:35610) |
| bielschowskysin (CHEBI:65497) has role antineoplastic agent (CHEBI:35610) |
| bigelovin (CHEBI:69337) has role antineoplastic agent (CHEBI:35610) |
| BIIB021 (CHEBI:90687) has role antineoplastic agent (CHEBI:35610) |
| binimetinib (CHEBI:145371) has role antineoplastic agent (CHEBI:35610) |
| biochanin A (CHEBI:17574) has role antineoplastic agent (CHEBI:35610) |
| bis(S-citronellalthiosemicarbazonato)nickel(II) (CHEBI:156433) has role antineoplastic agent (CHEBI:35610) |
| bisantrene (CHEBI:88337) has role antineoplastic agent (CHEBI:35610) |
| bistratamide E (CHEBI:65504) has role antineoplastic agent (CHEBI:35610) |
| bistratamide F (CHEBI:65505) has role antineoplastic agent (CHEBI:35610) |
| bistratamide G (CHEBI:65506) has role antineoplastic agent (CHEBI:35610) |
| bistratamide H (CHEBI:65507) has role antineoplastic agent (CHEBI:35610) |
| bistratamide I (CHEBI:65508) has role antineoplastic agent (CHEBI:35610) |
| bistratamide J (CHEBI:65509) has role antineoplastic agent (CHEBI:35610) |
| BKM120 (CHEBI:71954) has role antineoplastic agent (CHEBI:35610) |
| bleomycin A2 (CHEBI:3139) has role antineoplastic agent (CHEBI:35610) |
| bleomycin A5 (CHEBI:78160) has role antineoplastic agent (CHEBI:35610) |
| bleomycin B2 (CHEBI:28641) has role antineoplastic agent (CHEBI:35610) |
| bleomycin hydrochloride (CHEBI:78353) has role antineoplastic agent (CHEBI:35610) |
| BML-210 (CHEBI:61077) has role antineoplastic agent (CHEBI:35610) |
| BMS-214662 (CHEBI:167655) has role antineoplastic agent (CHEBI:35610) |
| BMS-754807 (CHEBI:88339) has role antineoplastic agent (CHEBI:35610) |
| BMY-25067 (CHEBI:195316) has role antineoplastic agent (CHEBI:35610) |
| borrelidin (CHEBI:78661) has role antineoplastic agent (CHEBI:35610) |
| bortezomib (CHEBI:52717) has role antineoplastic agent (CHEBI:35610) |
| bosutinib (CHEBI:39112) has role antineoplastic agent (CHEBI:35610) |
| bosutinib hydrate (CHEBI:68533) has role antineoplastic agent (CHEBI:35610) |
| bouvardin (CHEBI:233285) has role antineoplastic agent (CHEBI:35610) |
| bowdichione (CHEBI:3162) has role antineoplastic agent (CHEBI:35610) |
| BPDZ 711 (CHEBI:138512) has role antineoplastic agent (CHEBI:35610) |
| brasilicardin A (CHEBI:65513) has role antineoplastic agent (CHEBI:35610) |
| brasiliquinone A (CHEBI:65516) has role antineoplastic agent (CHEBI:35610) |
| brasiliquinone B (CHEBI:65517) has role antineoplastic agent (CHEBI:35610) |
| brasiliquinone C (CHEBI:65518) has role antineoplastic agent (CHEBI:35610) |
| brasixanthone B (CHEBI:65519) has role antineoplastic agent (CHEBI:35610) |
| brasixanthone C (CHEBI:65520) has role antineoplastic agent (CHEBI:35610) |
| brasixanthone D (CHEBI:65521) has role antineoplastic agent (CHEBI:35610) |
| brazilein (CHEBI:69196) has role antineoplastic agent (CHEBI:35610) |
| brazilin (CHEBI:3170) has role antineoplastic agent (CHEBI:35610) |
| brequinar (CHEBI:177387) has role antineoplastic agent (CHEBI:35610) |
| brequinar sodium (CHEBI:177871) has role antineoplastic agent (CHEBI:35610) |
| brevipolide A (CHEBI:65522) has role antineoplastic agent (CHEBI:35610) |
| brevipolide B (CHEBI:65523) has role antineoplastic agent (CHEBI:35610) |
| breynceanothanolic acid (CHEBI:67583) has role antineoplastic agent (CHEBI:35610) |
| brigatinib (CHEBI:232810) has role antineoplastic agent (CHEBI:35610) |
| brivanib (CHEBI:167686) has role antineoplastic agent (CHEBI:35610) |
| brivanib alaninate (CHEBI:167656) has role antineoplastic agent (CHEBI:35610) |
| bromophycolide A (CHEBI:65525) has role antineoplastic agent (CHEBI:35610) |
| bromotopsentin (CHEBI:144088) has role antineoplastic agent (CHEBI:35610) |
| bruceanol D (CHEBI:65526) has role antineoplastic agent (CHEBI:35610) |
| bruceanol E (CHEBI:65527) has role antineoplastic agent (CHEBI:35610) |
| bruceanol F (CHEBI:65528) has role antineoplastic agent (CHEBI:35610) |
| bruceine D (CHEBI:68931) has role antineoplastic agent (CHEBI:35610) |
| bruceolide (CHEBI:65529) has role antineoplastic agent (CHEBI:35610) |
| bryostatin 1 (CHEBI:88353) has role antineoplastic agent (CHEBI:35610) |
| bryostatin 2 (CHEBI:139177) has role antineoplastic agent (CHEBI:35610) |
| bufalin (CHEBI:517248) has role antineoplastic agent (CHEBI:35610) |
| buformin (CHEBI:3209) has role antineoplastic agent (CHEBI:35610) |
| burseran (CHEBI:3222) has role antineoplastic agent (CHEBI:35610) |
| busulfan (CHEBI:28901) has role antineoplastic agent (CHEBI:35610) |
| butein (CHEBI:3237) has role antineoplastic agent (CHEBI:35610) |
| C-1027 chromophore (CHEBI:3252) has role antineoplastic agent (CHEBI:35610) |
| C75 (CHEBI:189865) has role antineoplastic agent (CHEBI:35610) |
| cabazitaxel (CHEBI:63584) has role antineoplastic agent (CHEBI:35610) |
| cabergoline (CHEBI:3286) has role antineoplastic agent (CHEBI:35610) |
| cabozantinib (CHEBI:72317) has role antineoplastic agent (CHEBI:35610) |
| cabozantinib malate (CHEBI:72319) has role antineoplastic agent (CHEBI:35610) |
| cadiyenol (CHEBI:65538) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin A (CHEBI:69231) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin C (CHEBI:69232) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin F (CHEBI:69225) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin G (CHEBI:69226) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin H (CHEBI:69227) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin I (CHEBI:69228) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin J (CHEBI:69229) has role antineoplastic agent (CHEBI:35610) |
| caerulomycin K (CHEBI:69230) has role antineoplastic agent (CHEBI:35610) |
| caerulomycinamide (CHEBI:69233) has role antineoplastic agent (CHEBI:35610) |
| caerulomycinonitrile (CHEBI:69234) has role antineoplastic agent (CHEBI:35610) |
| cafestol (CHEBI:3291) has role antineoplastic agent (CHEBI:35610) |
| calcitriol (CHEBI:17823) has role antineoplastic agent (CHEBI:35610) |
| calicheamicin γ1I (CHEBI:3319) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid A (CHEBI:65557) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid C (CHEBI:65559) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid D (CHEBI:65560) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid E (CHEBI:65561) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid F (CHEBI:65562) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid G (CHEBI:65563) has role antineoplastic agent (CHEBI:35610) |
| callophycoic acid H (CHEBI:65564) has role antineoplastic agent (CHEBI:35610) |
| callophycol A (CHEBI:65565) has role antineoplastic agent (CHEBI:35610) |
| callophycol B (CHEBI:65566) has role antineoplastic agent (CHEBI:35610) |
| calotropone (CHEBI:65568) has role antineoplastic agent (CHEBI:35610) |
| camonsertib (CHEBI:229722) has role antineoplastic agent (CHEBI:35610) |
| camostat (CHEBI:135632) has role antineoplastic agent (CHEBI:35610) |
| camostat mesylate (CHEBI:31347) has role antineoplastic agent (CHEBI:35610) |
| camptothecin (CHEBI:27656) has role antineoplastic agent (CHEBI:35610) |
| CAN-508 (CHEBI:42356) has role antineoplastic agent (CHEBI:35610) |
| canertinib (CHEBI:61399) has role antineoplastic agent (CHEBI:35610) |
| capecitabine (CHEBI:31348) has role antineoplastic agent (CHEBI:35610) |
| capilliposide B (CHEBI:65574) has role antineoplastic agent (CHEBI:35610) |
| capivasertib (CHEBI:229222) has role antineoplastic agent (CHEBI:35610) |
| capmatinib (CHEBI:231693) has role antineoplastic agent (CHEBI:35610) |
| carbonarone A (CHEBI:69403) has role antineoplastic agent (CHEBI:35610) |
| carboplatin (CHEBI:31355) has role antineoplastic agent (CHEBI:35610) |
| cardivin A (CHEBI:65576) has role antineoplastic agent (CHEBI:35610) |
| cardivin B (CHEBI:65577) has role antineoplastic agent (CHEBI:35610) |
| cardivin C (CHEBI:65578) has role antineoplastic agent (CHEBI:35610) |
| cardivin D (CHEBI:65579) has role antineoplastic agent (CHEBI:35610) |
| carfilzomib (CHEBI:65347) has role antineoplastic agent (CHEBI:35610) |
| carminomycin (CHEBI:31359) has role antineoplastic agent (CHEBI:35610) |
| carmustine (CHEBI:3423) has role antineoplastic agent (CHEBI:35610) |
| carnosic acid (CHEBI:65585) has role antineoplastic agent (CHEBI:35610) |
| carnosine (CHEBI:15727) has role antineoplastic agent (CHEBI:35610) |
| caseamemebrol A (CHEBI:65586) has role antineoplastic agent (CHEBI:35610) |
| caseamemebrol B (CHEBI:65587) has role antineoplastic agent (CHEBI:35610) |
| caseanigrescen A (CHEBI:65588) has role antineoplastic agent (CHEBI:35610) |
| caseanigrescen B (CHEBI:65589) has role antineoplastic agent (CHEBI:35610) |
| caseanigrescen C (CHEBI:65590) has role antineoplastic agent (CHEBI:35610) |
| caseanigrescen D (CHEBI:65591) has role antineoplastic agent (CHEBI:35610) |
| Casiopeina II-gly (CHEBI:232493) has role antineoplastic agent (CHEBI:35610) |
| caudatin-3-O-β-cymaropyranoside (CHEBI:65603) has role antineoplastic agent (CHEBI:35610) |
| CB-103 (CHEBI:232592) has role antineoplastic agent (CHEBI:35610) |
| CBL0137 (CHEBI:138650) has role antineoplastic agent (CHEBI:35610) |
| CCT-018159 (CHEBI:41656) has role antineoplastic agent (CHEBI:35610) |
| CCT251545 (CHEBI:143114) has role antineoplastic agent (CHEBI:35610) |
| CD532 (CHEBI:83432) has role antineoplastic agent (CHEBI:35610) |
| celastrol (CHEBI:63959) has role antineoplastic agent (CHEBI:35610) |
| celebixanthone (CHEBI:65606) has role antineoplastic agent (CHEBI:35610) |
| cembra-2,7,11-triene-4,6-diol (CHEBI:525464) has role antineoplastic agent (CHEBI:35610) |
| centaureidin (CHEBI:69356) has role antineoplastic agent (CHEBI:35610) |
| cerberin (CHEBI:75049) has role antineoplastic agent (CHEBI:35610) |
| ceritinib (CHEBI:78432) has role antineoplastic agent (CHEBI:35610) |
| cetrorelix (CHEBI:59224) has role antineoplastic agent (CHEBI:35610) |
| cetrorelix acetate (CHEBI:31387) has role antineoplastic agent (CHEBI:35610) |
| CG-1521 (CHEBI:156510) has role antineoplastic agent (CHEBI:35610) |
| CGP-42112A (CHEBI:147302) has role antineoplastic agent (CHEBI:35610) |
| CGS 15943 (CHEBI:131351) has role antineoplastic agent (CHEBI:35610) |
| CH5126766 (CHEBI:78825) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin B (CHEBI:68734) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin D (CHEBI:68807) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin E (CHEBI:68731) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin F (CHEBI:68732) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin G (CHEBI:68813) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin J (CHEBI:68735) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin L (CHEBI:68775) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin Q (CHEBI:68736) has role antineoplastic agent (CHEBI:35610) |
| chaetoglobosin T (CHEBI:68738) has role antineoplastic agent (CHEBI:35610) |
| chelerythrine (CHEBI:78373) has role antineoplastic agent (CHEBI:35610) |
| CHIR-265 (CHEBI:91451) has role antineoplastic agent (CHEBI:35610) |
| CHIR-98014 (CHEBI:167657) has role antineoplastic agent (CHEBI:35610) |
| chlorambucil (CHEBI:28830) has role antineoplastic agent (CHEBI:35610) |
| chlorotrianisene (CHEBI:3641) has role antineoplastic agent (CHEBI:35610) |
| chondramide A (CHEBI:84380) has role antineoplastic agent (CHEBI:35610) |
| chondramide B (CHEBI:84381) has role antineoplastic agent (CHEBI:35610) |
| chondramide C (CHEBI:84382) has role antineoplastic agent (CHEBI:35610) |
| chondramide D (CHEBI:84383) has role antineoplastic agent (CHEBI:35610) |
| chrysin (CHEBI:75095) has role antineoplastic agent (CHEBI:35610) |
| chrysosplenol C (CHEBI:3690) has role antineoplastic agent (CHEBI:35610) |
| CHZ868 (CHEBI:90828) has role antineoplastic agent (CHEBI:35610) |
| cidofovir anhydrous (CHEBI:3696) has role antineoplastic agent (CHEBI:35610) |
| cidofovir dihydrate (CHEBI:59495) has role antineoplastic agent (CHEBI:35610) |
| CIGB-300 (CHEBI:83696) has role antineoplastic agent (CHEBI:35610) |
| ciglitazone (CHEBI:64227) has role antineoplastic agent (CHEBI:35610) |
| ciliatamide B (CHEBI:65631) has role antineoplastic agent (CHEBI:35610) |
| cirsilineol (CHEBI:3718) has role antineoplastic agent (CHEBI:35610) |
| cisplatin (CHEBI:27899) has role antineoplastic agent (CHEBI:35610) |
| cladoniamide G (CHEBI:65639) has role antineoplastic agent (CHEBI:35610) |
| cladribine (CHEBI:567361) has role antineoplastic agent (CHEBI:35610) |
| clavulone II (CHEBI:34643) has role antineoplastic agent (CHEBI:35610) |
| clethroidoside C (CHEBI:69603) has role antineoplastic agent (CHEBI:35610) |
| clethroidoside D (CHEBI:69604) has role antineoplastic agent (CHEBI:35610) |
| clethroidoside F (CHEBI:69606) has role antineoplastic agent (CHEBI:35610) |
| clionastatin A (CHEBI:65644) has role antineoplastic agent (CHEBI:35610) |
| clionastatin B (CHEBI:65645) has role antineoplastic agent (CHEBI:35610) |
| clodronic acid (CHEBI:110423) has role antineoplastic agent (CHEBI:35610) |
| clofarabine (CHEBI:681569) has role antineoplastic agent (CHEBI:35610) |
| clofibric acid (CHEBI:34648) has role antineoplastic agent (CHEBI:35610) |
| CM-272 (CHEBI:229970) has role antineoplastic agent (CHEBI:35610) |
| CNDAC (CHEBI:145435) has role antineoplastic agent (CHEBI:35610) |
| cobimetinib (CHEBI:90851) has role antineoplastic agent (CHEBI:35610) |
| cobimetinib fumarate (CHEBI:90853) has role antineoplastic agent (CHEBI:35610) |
| cochinchinone A (CHEBI:65646) has role antineoplastic agent (CHEBI:35610) |
| cochinchinoxanthone (CHEBI:67545) has role antineoplastic agent (CHEBI:35610) |
| colpol (CHEBI:65652) has role antineoplastic agent (CHEBI:35610) |
| columbianadin (CHEBI:132624) has role antineoplastic agent (CHEBI:35610) |
| comazaphilone D (CHEBI:70013) has role antineoplastic agent (CHEBI:35610) |
| comazaphilone E (CHEBI:70014) has role antineoplastic agent (CHEBI:35610) |
| comazaphilone F (CHEBI:70015) has role antineoplastic agent (CHEBI:35610) |
| copanlisib (CHEBI:173077) has role antineoplastic agent (CHEBI:35610) |
| copanlisib dihydrochloride (CHEBI:173081) has role antineoplastic agent (CHEBI:35610) |
| cordycepin triphosphate (CHEBI:52316) has role antineoplastic agent (CHEBI:35610) |
| cordyol C (CHEBI:64518) has role antineoplastic agent (CHEBI:35610) |
| corynoline (CHEBI:65660) has role antineoplastic agent (CHEBI:35610) |
| costunolide (CHEBI:3900) has role antineoplastic agent (CHEBI:35610) |
| coumermycin A1 (CHEBI:3907) has role antineoplastic agent (CHEBI:35610) |
| CP-724714 (CHEBI:167658) has role antineoplastic agent (CHEBI:35610) |
| CP681301 (CHEBI:232980) has role antineoplastic agent (CHEBI:35610) |
| crassolide (CHEBI:65669) has role antineoplastic agent (CHEBI:35610) |
| crassumolide A (CHEBI:65670) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone A (CHEBI:65671) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone B (CHEBI:65672) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone C (CHEBI:65673) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone D (CHEBI:65674) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone E (CHEBI:65675) has role antineoplastic agent (CHEBI:35610) |
| cratoxyarborenone F (CHEBI:65676) has role antineoplastic agent (CHEBI:35610) |
| cratoxylumxanthone C (CHEBI:195283) has role antineoplastic agent (CHEBI:35610) |
| cremeomycin (CHEBI:184373) has role antineoplastic agent (CHEBI:35610) |
| crenolanib (CHEBI:145365) has role antineoplastic agent (CHEBI:35610) |
| crizotinib (CHEBI:64310) has role antineoplastic agent (CHEBI:35610) |
| cryptolepine (CHEBI:3930) has role antineoplastic agent (CHEBI:35610) |
| cryptopleurine (CHEBI:3932) has role antineoplastic agent (CHEBI:35610) |
| CT-179 (CHEBI:234076) has role antineoplastic agent (CHEBI:35610) |
| cucurbitacin E 2-O-β-D-glucopyranoside (CHEBI:68916) has role antineoplastic agent (CHEBI:35610) |
| cucurbitacin I (CHEBI:3947) has role antineoplastic agent (CHEBI:35610) |
| cudraflavone C (CHEBI:68023) has role antineoplastic agent (CHEBI:35610) |
| cudratricusxanthone A (CHEBI:65686) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside A (CHEBI:65689) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside B (CHEBI:65690) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside C (CHEBI:65691) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside D (CHEBI:65692) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside E (CHEBI:65693) has role antineoplastic agent (CHEBI:35610) |
| cumingianoside F (CHEBI:65694) has role antineoplastic agent (CHEBI:35610) |
| curacozole (CHEBI:156428) has role antineoplastic agent (CHEBI:35610) |
| curcumin (CHEBI:3962) has role antineoplastic agent (CHEBI:35610) |
| CX-5461 (CHEBI:156287) has role antineoplastic agent (CHEBI:35610) |
| cyclodepsipeptide 2 (CHEBI:66300) has role antineoplastic agent (CHEBI:35610) |
| cyclophosphamide (CHEBI:4027) has role antineoplastic agent (CHEBI:35610) |
| cyclophosphamide hydrate (CHEBI:4026) has role antineoplastic agent (CHEBI:35610) |
| cystodytin D (CHEBI:65710) has role antineoplastic agent (CHEBI:35610) |
| cystodytin E (CHEBI:65711) has role antineoplastic agent (CHEBI:35610) |
| cystodytin F (CHEBI:65712) has role antineoplastic agent (CHEBI:35610) |
| cystodytin G (CHEBI:65713) has role antineoplastic agent (CHEBI:35610) |
| cystodytin H (CHEBI:65714) has role antineoplastic agent (CHEBI:35610) |
| cystodytin I (CHEBI:65715) has role antineoplastic agent (CHEBI:35610) |
| cystothiazole A (CHEBI:65716) has role antineoplastic agent (CHEBI:35610) |
| cytarabine (CHEBI:28680) has role antineoplastic agent (CHEBI:35610) |
| cytochalasin D (CHEBI:529996) has role antineoplastic agent (CHEBI:35610) |
| cytoglobosin C (CHEBI:68761) has role antineoplastic agent (CHEBI:35610) |
| cytoglobosin D (CHEBI:68762) has role antineoplastic agent (CHEBI:35610) |
| cytotrienin A (CHEBI:65720) has role antineoplastic agent (CHEBI:35610) |
| dabrafenib (CHEBI:75045) has role antineoplastic agent (CHEBI:35610) |
| dabrafenib mesylate (CHEBI:75048) has role antineoplastic agent (CHEBI:35610) |
| dacarbazine (CHEBI:4305) has role antineoplastic agent (CHEBI:35610) |
| dacomitinib (CHEBI:132268) has role antineoplastic agent (CHEBI:35610) |
| dactolisib (CHEBI:71952) has role antineoplastic agent (CHEBI:35610) |
| daidzein (CHEBI:28197) has role antineoplastic agent (CHEBI:35610) |
| daidzein(1−) (CHEBI:77764) has role antineoplastic agent (CHEBI:35610) |
| daphnoretin (CHEBI:4324) has role antineoplastic agent (CHEBI:35610) |
| daraxonrasib (CHEBI:746946) has role antineoplastic agent (CHEBI:35610) |
| dasatinib (anhydrous) (CHEBI:49375) has role antineoplastic agent (CHEBI:35610) |
| dasatinib monohydrate (CHEBI:70839) has role antineoplastic agent (CHEBI:35610) |
| daunorubicin (CHEBI:41977) has role antineoplastic agent (CHEBI:35610) |
| DC_517 (CHEBI:229971) has role antineoplastic agent (CHEBI:35610) |
| deacetyltanghinin (CHEBI:66193) has role antineoplastic agent (CHEBI:35610) |
| decursinol (CHEBI:4354) has role antineoplastic agent (CHEBI:35610) |
| Defencath (CHEBI:230518) has role antineoplastic agent (CHEBI:35610) |
| deguelin (CHEBI:4357) has role antineoplastic agent (CHEBI:35610) |
| dehydrocostus lactone (CHEBI:244418) has role antineoplastic agent (CHEBI:35610) |
| DEL-22379 (CHEBI:90905) has role antineoplastic agent (CHEBI:35610) |
| delanzomib (CHEBI:141530) has role antineoplastic agent (CHEBI:35610) |
| delphinidin (CHEBI:28436) has role antineoplastic agent (CHEBI:35610) |
| delphinidin(1−) (CHEBI:144775) has role antineoplastic agent (CHEBI:35610) |
| demethoxycurcumin (CHEBI:65737) has role antineoplastic agent (CHEBI:35610) |
| deoxylapachol (CHEBI:4414) has role antineoplastic agent (CHEBI:35610) |
| deoxypodophyllotoxin (CHEBI:4429) has role antineoplastic agent (CHEBI:35610) |
| dequalinium (CHEBI:41872) has role antineoplastic agent (CHEBI:35610) |
| dequalinium chloride (CHEBI:31466) has role antineoplastic agent (CHEBI:35610) |
| desferrioxamine E (CHEBI:50437) has role antineoplastic agent (CHEBI:35610) |
| devazepide (CHEBI:4460) has role antineoplastic agent (CHEBI:35610) |
| devimistat (CHEBI:233197) has role antineoplastic agent (CHEBI:35610) |
| dexamethasone (CHEBI:41879) has role antineoplastic agent (CHEBI:35610) |
| dexormaplatin (CHEBI:85605) has role antineoplastic agent (CHEBI:35610) |
| dexrazoxane hydrochloride (CHEBI:50224) has role antineoplastic agent (CHEBI:35610) |
| DH334 (CHEBI:82662) has role antineoplastic agent (CHEBI:35610) |
| DH334(1+) (CHEBI:82666) has role antineoplastic agent (CHEBI:35610) |
| diallyl disulfide (CHEBI:4488) has role antineoplastic agent (CHEBI:35610) |
| diallyl trisulfide (CHEBI:78492) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside A (CHEBI:65755) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside B (CHEBI:65756) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside C (CHEBI:65757) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside D (CHEBI:65758) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside E (CHEBI:65759) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside F (CHEBI:65760) has role antineoplastic agent (CHEBI:35610) |
| dianversicoside G (CHEBI:65761) has role antineoplastic agent (CHEBI:35610) |
| diarsenic trioxide (CHEBI:30621) has role antineoplastic agent (CHEBI:35610) |
| diazepinomicin (CHEBI:156321) has role antineoplastic agent (CHEBI:35610) |
| diaziquone (CHEBI:90185) has role antineoplastic agent (CHEBI:35610) |
| diazomethane (CHEBI:73716) has role antineoplastic agent (CHEBI:35610) |
| dibenzoylmethane (CHEBI:75417) has role antineoplastic agent (CHEBI:35610) |
| dicerandrol A (CHEBI:65764) has role antineoplastic agent (CHEBI:35610) |
| dicerandrol B (CHEBI:65765) has role antineoplastic agent (CHEBI:35610) |
| dicerandrol C (CHEBI:65766) has role antineoplastic agent (CHEBI:35610) |
| diethylstilbestrol (CHEBI:41922) has role antineoplastic agent (CHEBI:35610) |
| diflomotecan (CHEBI:144046) has role antineoplastic agent (CHEBI:35610) |
| dihydromotuporamine C (CHEBI:82642) has role antineoplastic agent (CHEBI:35610) |
| dilopholide (CHEBI:65794) has role antineoplastic agent (CHEBI:35610) |
| dinaciclib (CHEBI:95060) has role antineoplastic agent (CHEBI:35610) |
| dinochrome A (CHEBI:65797) has role antineoplastic agent (CHEBI:35610) |
| dioscin (CHEBI:74023) has role antineoplastic agent (CHEBI:35610) |
| diosgenin (CHEBI:4629) has role antineoplastic agent (CHEBI:35610) |
| diosmetin (CHEBI:4630) has role antineoplastic agent (CHEBI:35610) |
| diplotrin B (CHEBI:69448) has role antineoplastic agent (CHEBI:35610) |
| disulfiram (CHEBI:4659) has role antineoplastic agent (CHEBI:35610) |
| diuvaretin (CHEBI:65802) has role antineoplastic agent (CHEBI:35610) |
| divaricoside (CHEBI:4668) has role antineoplastic agent (CHEBI:35610) |
| DMH1 (CHEBI:86289) has role antineoplastic agent (CHEBI:35610) |
| DMH4 (CHEBI:229963) has role antineoplastic agent (CHEBI:35610) |
| docetaxel anhydrous (CHEBI:4672) has role antineoplastic agent (CHEBI:35610) |
| docetaxel trihydrate (CHEBI:59809) has role antineoplastic agent (CHEBI:35610) |
| dolastatin 10 (CHEBI:67357) has role antineoplastic agent (CHEBI:35610) |
| dordaviprone (CHEBI:232328) has role antineoplastic agent (CHEBI:35610) |
| doxazosin (CHEBI:4708) has role antineoplastic agent (CHEBI:35610) |
| doxifluridine (CHEBI:31521) has role antineoplastic agent (CHEBI:35610) |
| dromostanolone propionate (CHEBI:31523) has role antineoplastic agent (CHEBI:35610) |
| DS-1-38 (CHEBI:231606) has role antineoplastic agent (CHEBI:35610) |
| dutomycin (CHEBI:171673) has role antineoplastic agent (CHEBI:35610) |
| E-3810 (CHEBI:65138) has role antineoplastic agent (CHEBI:35610) |
| E-3810 free base (CHEBI:65209) has role antineoplastic agent (CHEBI:35610) |
| ebselen (CHEBI:77543) has role antineoplastic agent (CHEBI:35610) |
| edelfosine (CHEBI:78649) has role antineoplastic agent (CHEBI:35610) |
| EG00229 (CHEBI:166820) has role antineoplastic agent (CHEBI:35610) |
| ekatetrone (CHEBI:141382) has role antineoplastic agent (CHEBI:35610) |
| elacestrant (CHEBI:229213) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside B (CHEBI:65825) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside F (CHEBI:65826) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside G (CHEBI:65827) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside T (CHEBI:65828) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside U (CHEBI:65829) has role antineoplastic agent (CHEBI:35610) |
| elaeodendroside W (CHEBI:65831) has role antineoplastic agent (CHEBI:35610) |
| elaidylphosphocholine (CHEBI:75487) has role antineoplastic agent (CHEBI:35610) |
| elephantin (CHEBI:520527) has role antineoplastic agent (CHEBI:35610) |
| elesclomol (CHEBI:79369) has role antineoplastic agent (CHEBI:35610) |
| elesclomol-Cu(II) (CHEBI:79377) has role antineoplastic agent (CHEBI:35610) |
| elisidepsin (CHEBI:83152) has role antineoplastic agent (CHEBI:35610) |
| ellipticine (CHEBI:4776) has role antineoplastic agent (CHEBI:35610) |
| elongatol A (CHEBI:65837) has role antineoplastic agent (CHEBI:35610) |
| elongatol E (CHEBI:65838) has role antineoplastic agent (CHEBI:35610) |
| eltanexor (CHEBI:229762) has role antineoplastic agent (CHEBI:35610) |
| emarginatine B (CHEBI:65839) has role antineoplastic agent (CHEBI:35610) |
| emarginatine F (CHEBI:65840) has role antineoplastic agent (CHEBI:35610) |
| embelin (CHEBI:4778) has role antineoplastic agent (CHEBI:35610) |
| emetine (CHEBI:4781) has role antineoplastic agent (CHEBI:35610) |
| emetine dihydrochloride (CHEBI:149551) has role antineoplastic agent (CHEBI:35610) |
| emetine dihydrochloride hydrate (CHEBI:146000) has role antineoplastic agent (CHEBI:35610) |
| emodin (CHEBI:42223) has role antineoplastic agent (CHEBI:35610) |
| emodin(1−) (CHEBI:77659) has role antineoplastic agent (CHEBI:35610) |
| enasidenib (CHEBI:145374) has role antineoplastic agent (CHEBI:35610) |
| englerin A (CHEBI:72441) has role antineoplastic agent (CHEBI:35610) |
| enitociclib (CHEBI:231682) has role antineoplastic agent (CHEBI:35610) |
| enrofloxacin (CHEBI:35720) has role antineoplastic agent (CHEBI:35610) |
| entinostat (CHEBI:132082) has role antineoplastic agent (CHEBI:35610) |
| entrectinib (CHEBI:195558) has role antineoplastic agent (CHEBI:35610) |
| enzalutamide (CHEBI:68534) has role antineoplastic agent (CHEBI:35610) |
| epirubicin hydrochloride (CHEBI:232543) has role antineoplastic agent (CHEBI:35610) |
| epothilone A (CHEBI:31549) has role antineoplastic agent (CHEBI:35610) |
| epothilone B (CHEBI:31550) has role antineoplastic agent (CHEBI:35610) |
| erastin (CHEBI:94287) has role antineoplastic agent (CHEBI:35610) |
| erdasporine A (CHEBI:156313) has role antineoplastic agent (CHEBI:35610) |
| erdasporine B (CHEBI:156314) has role antineoplastic agent (CHEBI:35610) |
| erdasporine C (CHEBI:156315) has role antineoplastic agent (CHEBI:35610) |
| ergolide (CHEBI:69340) has role antineoplastic agent (CHEBI:35610) |
| ergosterol peroxide (CHEBI:65858) has role antineoplastic agent (CHEBI:35610) |
| erianin (CHEBI:233659) has role antineoplastic agent (CHEBI:35610) |
| eribulin (CHEBI:63587) has role antineoplastic agent (CHEBI:35610) |
| eribulin mesylate (CHEBI:70710) has role antineoplastic agent (CHEBI:35610) |
| erlotinib (CHEBI:114785) has role antineoplastic agent (CHEBI:35610) |
| erlotinib hydrochloride (CHEBI:53509) has role antineoplastic agent (CHEBI:35610) |
| erteberel (CHEBI:231600) has role antineoplastic agent (CHEBI:35610) |
| erybraedin A (CHEBI:65862) has role antineoplastic agent (CHEBI:35610) |
| esculeoside A (CHEBI:65866) has role antineoplastic agent (CHEBI:35610) |
| esperamicin A1 (CHEBI:53273) has role antineoplastic agent (CHEBI:35610) |
| estramustine (CHEBI:4868) has role antineoplastic agent (CHEBI:35610) |
| estrone (CHEBI:17263) has role antineoplastic agent (CHEBI:35610) |
| etanidazole (CHEBI:75473) has role antineoplastic agent (CHEBI:35610) |
| ethyl trans-caffeate (CHEBI:132714) has role antineoplastic agent (CHEBI:35610) |
| ethyl methanesulfonate (CHEBI:23994) has role antineoplastic agent (CHEBI:35610) |
| etidronate disodium (CHEBI:4906) has role antineoplastic agent (CHEBI:35610) |
| etidronic acid (CHEBI:4907) has role antineoplastic agent (CHEBI:35610) |
| etoposide (CHEBI:4911) has role antineoplastic agent (CHEBI:35610) |
| eucalyptal A (CHEBI:65869) has role antineoplastic agent (CHEBI:35610) |
| eucalyptal B (CHEBI:65870) has role antineoplastic agent (CHEBI:35610) |
| eucalyptal C (CHEBI:65871) has role antineoplastic agent (CHEBI:35610) |
| eudistomin C (CHEBI:80955) has role antineoplastic agent (CHEBI:35610) |
| eugeniin (CHEBI:4916) has role antineoplastic agent (CHEBI:35610) |
| eugenol (CHEBI:4917) has role antineoplastic agent (CHEBI:35610) |
| eupaheliangolide A (CHEBI:65879) has role antineoplastic agent (CHEBI:35610) |
| eupatilin (CHEBI:4932) has role antineoplastic agent (CHEBI:35610) |
| eupatolide (CHEBI:4935) has role antineoplastic agent (CHEBI:35610) |
| eupatorin (CHEBI:136666) has role antineoplastic agent (CHEBI:35610) |
| euphornin L (CHEBI:65886) has role antineoplastic agent (CHEBI:35610) |
| eurycomanone (CHEBI:65887) has role antineoplastic agent (CHEBI:35610) |
| eurysterol A (CHEBI:65888) has role antineoplastic agent (CHEBI:35610) |
| eurysterol A sulfonic acid (CHEBI:68591) has role antineoplastic agent (CHEBI:35610) |
| eurysterol B (CHEBI:65889) has role antineoplastic agent (CHEBI:35610) |
| eurysterol B sulfonic acid (CHEBI:68594) has role antineoplastic agent (CHEBI:35610) |
| everolimus (CHEBI:68478) has role antineoplastic agent (CHEBI:35610) |
| evofosfamide (CHEBI:231678) has role antineoplastic agent (CHEBI:35610) |
| EVP4593 (CHEBI:232358) has role antineoplastic agent (CHEBI:35610) |
| exemestane (CHEBI:4953) has role antineoplastic agent (CHEBI:35610) |
| F-14512 (CHEBI:232860) has role antineoplastic agent (CHEBI:35610) |
| F390B (CHEBI:65893) has role antineoplastic agent (CHEBI:35610) |
| F390C (CHEBI:65894) has role antineoplastic agent (CHEBI:35610) |
| fangchinoline (CHEBI:132893) has role antineoplastic agent (CHEBI:35610) |
| fazarabine (CHEBI:141077) has role antineoplastic agent (CHEBI:35610) |
| FD-211 (CHEBI:65896) has role antineoplastic agent (CHEBI:35610) |
| ferroptocide (CHEBI:173106) has role antineoplastic agent (CHEBI:35610) |
| ferruginol (CHEBI:78274) has role antineoplastic agent (CHEBI:35610) |
| fingolimod (CHEBI:63115) has role antineoplastic agent (CHEBI:35610) |
| fingolimod phosphate (CHEBI:73420) has role antineoplastic agent (CHEBI:35610) |
| FINO2 (CHEBI:176420) has role antineoplastic agent (CHEBI:35610) |
| firocoxib (CHEBI:76136) has role antineoplastic agent (CHEBI:35610) |
| flavokawain B (CHEBI:65899) has role antineoplastic agent (CHEBI:35610) |
| floxuridine (CHEBI:60761) has role antineoplastic agent (CHEBI:35610) |
| fludarabine phosphate (CHEBI:63599) has role antineoplastic agent (CHEBI:35610) |
| flumatinib (CHEBI:233593) has role antineoplastic agent (CHEBI:35610) |
| fluopsin C (CHEBI:222417) has role antineoplastic agent (CHEBI:35610) |
| fluoxymesterone (CHEBI:5120) has role antineoplastic agent (CHEBI:35610) |
| flutamide (CHEBI:5132) has role antineoplastic agent (CHEBI:35610) |
| foretinib (CHEBI:91418) has role antineoplastic agent (CHEBI:35610) |
| formestane (CHEBI:75172) has role antineoplastic agent (CHEBI:35610) |
| formycin A (CHEBI:42452) has role antineoplastic agent (CHEBI:35610) |
| fostriecin (CHEBI:167004) has role antineoplastic agent (CHEBI:35610) |
| fotemustine (CHEBI:131848) has role antineoplastic agent (CHEBI:35610) |
| FR901463 (CHEBI:65914) has role antineoplastic agent (CHEBI:35610) |
| FR901464 (CHEBI:65915) has role antineoplastic agent (CHEBI:35610) |
| FR901465 (CHEBI:65916) has role antineoplastic agent (CHEBI:35610) |
| fruquintinib (CHEBI:229221) has role antineoplastic agent (CHEBI:35610) |
| fruticoside A (CHEBI:67584) has role antineoplastic agent (CHEBI:35610) |
| fucoidan (CHEBI:5181) has role antineoplastic agent (CHEBI:35610) |
| fulvestrant (CHEBI:31638) has role antineoplastic agent (CHEBI:35610) |
| fusarithioamide A (CHEBI:141359) has role antineoplastic agent (CHEBI:35610) |
| fuzanin D (CHEBI:65939) has role antineoplastic agent (CHEBI:35610) |
| FX1 (CHEBI:133537) has role antineoplastic agent (CHEBI:35610) |
| G-1 (CHEBI:156296) has role antineoplastic agent (CHEBI:35610) |
| G-15 (CHEBI:156295) has role antineoplastic agent (CHEBI:35610) |
| G-573 (CHEBI:83404) has role antineoplastic agent (CHEBI:35610) |
| gallic acid (CHEBI:30778) has role antineoplastic agent (CHEBI:35610) |
| gallium nitrate (CHEBI:231505) has role antineoplastic agent (CHEBI:35610) |
| GANT61 (CHEBI:140908) has role antineoplastic agent (CHEBI:35610) |
| gardiquimod (CHEBI:234430) has role antineoplastic agent (CHEBI:35610) |
| gartanin (CHEBI:5279) has role antineoplastic agent (CHEBI:35610) |
| gartisertib (CHEBI:231616) has role antineoplastic agent (CHEBI:35610) |
| gastrin-17 (CHEBI:75441) has role antineoplastic agent (CHEBI:35610) |
| gaudichaudiic acid F (CHEBI:65950) has role antineoplastic agent (CHEBI:35610) |
| gaudichaudiic acid G (CHEBI:65951) has role antineoplastic agent (CHEBI:35610) |
| gaudichaudiic acid H (CHEBI:65952) has role antineoplastic agent (CHEBI:35610) |
| gaudichaudiic acid I (CHEBI:65953) has role antineoplastic agent (CHEBI:35610) |
| GDC-0326 (CHEBI:229938) has role antineoplastic agent (CHEBI:35610) |
| GDC-0623 (CHEBI:167659) has role antineoplastic agent (CHEBI:35610) |
| GDC-0879 (CHEBI:83405) has role antineoplastic agent (CHEBI:35610) |
| gedunin (CHEBI:65954) has role antineoplastic agent (CHEBI:35610) |
| gefitinib (CHEBI:49668) has role antineoplastic agent (CHEBI:35610) |
| geldanamycin (CHEBI:5292) has role antineoplastic agent (CHEBI:35610) |
| gelomulide K (CHEBI:65955) has role antineoplastic agent (CHEBI:35610) |
| gelomulide M (CHEBI:65956) has role antineoplastic agent (CHEBI:35610) |
| gemcitabine (CHEBI:175901) has role antineoplastic agent (CHEBI:35610) |
| gemcitabine hydrochloride (CHEBI:31647) has role antineoplastic agent (CHEBI:35610) |
| gemini-0072 (CHEBI:139243) has role antineoplastic agent (CHEBI:35610) |
| gemini-0097 (CHEBI:139244) has role antineoplastic agent (CHEBI:35610) |
| genistein (CHEBI:28088) has role antineoplastic agent (CHEBI:35610) |
| gentisyl alcohol (CHEBI:5325) has role antineoplastic agent (CHEBI:35610) |
| ghrelin (CHEBI:75431) has role antineoplastic agent (CHEBI:35610) |
| GI254023X (CHEBI:143102) has role antineoplastic agent (CHEBI:35610) |
| gibberosin K (CHEBI:65960) has role antineoplastic agent (CHEBI:35610) |
| gibberosin L (CHEBI:65961) has role antineoplastic agent (CHEBI:35610) |
| gigantetronenin (CHEBI:65962) has role antineoplastic agent (CHEBI:35610) |
| gigantrionenin (CHEBI:65963) has role antineoplastic agent (CHEBI:35610) |
| gilteritinib (CHEBI:145372) has role antineoplastic agent (CHEBI:35610) |
| gilvusmycin (CHEBI:65964) has role antineoplastic agent (CHEBI:35610) |
| gingerol (CHEBI:10136) has role antineoplastic agent (CHEBI:35610) |
| ginkgetin (CHEBI:5353) has role antineoplastic agent (CHEBI:35610) |
| ginkgolide B (CHEBI:5356) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside C-K (CHEBI:77146) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside F2 (CHEBI:77145) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside Mc (CHEBI:77491) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside Mx (CHEBI:77490) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside Re (CHEBI:77148) has role antineoplastic agent (CHEBI:35610) |
| ginsenoside Rf (CHEBI:67986) has role antineoplastic agent (CHEBI:35610) |
| givinostat (CHEBI:94187) has role antineoplastic agent (CHEBI:35610) |
| givinostat hydrochloride (CHEBI:231333) has role antineoplastic agent (CHEBI:35610) |
| givinostat hydrochloride monohydrate (CHEBI:231335) has role antineoplastic agent (CHEBI:35610) |
| glasdegib (CHEBI:145428) has role antineoplastic agent (CHEBI:35610) |
| glaucarubinone (CHEBI:5371) has role antineoplastic agent (CHEBI:35610) |
| glionitrin A (CHEBI:65967) has role antineoplastic agent (CHEBI:35610) |
| globostellatic acid A (CHEBI:72301) has role antineoplastic agent (CHEBI:35610) |
| globostellatic acid B (CHEBI:72304) has role antineoplastic agent (CHEBI:35610) |
| globostellatic acid C (CHEBI:72308) has role antineoplastic agent (CHEBI:35610) |
| globostellatic acid D (CHEBI:72310) has role antineoplastic agent (CHEBI:35610) |
| globosumone A (CHEBI:68705) has role antineoplastic agent (CHEBI:35610) |
| globosumone B (CHEBI:68706) has role antineoplastic agent (CHEBI:35610) |
| globosuxanthone A (CHEBI:68712) has role antineoplastic agent (CHEBI:35610) |
| glochierioside A (CHEBI:65973) has role antineoplastic agent (CHEBI:35610) |
| glochierioside B (CHEBI:65974) has role antineoplastic agent (CHEBI:35610) |
| Glu-Trp (CHEBI:73512) has role antineoplastic agent (CHEBI:35610) |
| glycyrol (CHEBI:80832) has role antineoplastic agent (CHEBI:35610) |
| gnidilatimonoein (CHEBI:65978) has role antineoplastic agent (CHEBI:35610) |
| granaticin (CHEBI:5533) has role antineoplastic agent (CHEBI:35610) |
| grassypeptolide (CHEBI:65980) has role antineoplastic agent (CHEBI:35610) |
| griffithane A (CHEBI:69700) has role antineoplastic agent (CHEBI:35610) |
| griffithane B (CHEBI:69701) has role antineoplastic agent (CHEBI:35610) |
| griffithane D (CHEBI:69703) has role antineoplastic agent (CHEBI:35610) |
| GSK-923295 (CHEBI:234356) has role antineoplastic agent (CHEBI:35610) |
| GSK-J1 (CHEBI:131152) has role antineoplastic agent (CHEBI:35610) |
| GSK-J4 (CHEBI:95077) has role antineoplastic agent (CHEBI:35610) |
| GSK046 (CHEBI:231669) has role antineoplastic agent (CHEBI:35610) |
| GSK1059615 (CHEBI:71955) has role antineoplastic agent (CHEBI:35610) |
| GSK126 (CHEBI:124921) has role antineoplastic agent (CHEBI:35610) |
| GSK2656157 (CHEBI:139047) has role antineoplastic agent (CHEBI:35610) |
| GSK2879552 (CHEBI:176334) has role antineoplastic agent (CHEBI:35610) |
| GSK343 (CHEBI:167693) has role antineoplastic agent (CHEBI:35610) |
| GSK461364 (CHEBI:91333) has role antineoplastic agent (CHEBI:35610) |
| GSK690693 (CHEBI:90677) has role antineoplastic agent (CHEBI:35610) |
| guanazole (CHEBI:75425) has role antineoplastic agent (CHEBI:35610) |
| gummiferaoside A (CHEBI:65986) has role antineoplastic agent (CHEBI:35610) |
| gummiferaoside B (CHEBI:65987) has role antineoplastic agent (CHEBI:35610) |
| gummiferaoside C (CHEBI:65988) has role antineoplastic agent (CHEBI:35610) |
| GW843682X (CHEBI:91334) has role antineoplastic agent (CHEBI:35610) |
| GYS32661 (CHEBI:197341) has role antineoplastic agent (CHEBI:35610) |
| H-Ala-Val-Pro-Ile-NH2 (CHEBI:234235) has role antineoplastic agent (CHEBI:35610) |
| HA15 (CHEBI:132781) has role antineoplastic agent (CHEBI:35610) |
| hadacidin (CHEBI:43040) has role antineoplastic agent (CHEBI:35610) |
| HC toxin (CHEBI:48028) has role antineoplastic agent (CHEBI:35610) |
| hedychilactone D (CHEBI:66009) has role antineoplastic agent (CHEBI:35610) |
| helenalin (CHEBI:5635) has role antineoplastic agent (CHEBI:35610) |
| heliangin (CHEBI:5638) has role antineoplastic agent (CHEBI:35610) |
| helioxanthin (CHEBI:191856) has role antineoplastic agent (CHEBI:35610) |
| hellebrigenin (CHEBI:38344) has role antineoplastic agent (CHEBI:35610) |
| helveticoside (CHEBI:5650) has role antineoplastic agent (CHEBI:35610) |
| herbacetin (CHEBI:27673) has role antineoplastic agent (CHEBI:35610) |
| hesperetin (CHEBI:28230) has role antineoplastic agent (CHEBI:35610) |
| HG-9-91-01 (CHEBI:133818) has role antineoplastic agent (CHEBI:35610) |
| himastatin (CHEBI:190009) has role antineoplastic agent (CHEBI:35610) |
| hinokiflavone (CHEBI:5721) has role antineoplastic agent (CHEBI:35610) |
| hippeastrine (CHEBI:5724) has role antineoplastic agent (CHEBI:35610) |
| hispidulin (CHEBI:75902) has role antineoplastic agent (CHEBI:35610) |
| histrelin (CHEBI:5739) has role antineoplastic agent (CHEBI:35610) |
| histrelin acetate (CHEBI:63530) has role antineoplastic agent (CHEBI:35610) |
| HMN-214 (CHEBI:91440) has role antineoplastic agent (CHEBI:35610) |
| holomycin (CHEBI:156451) has role antineoplastic agent (CHEBI:35610) |
| holothurin A3 (CHEBI:66018) has role antineoplastic agent (CHEBI:35610) |
| holothurin A4 (CHEBI:66019) has role antineoplastic agent (CHEBI:35610) |
| horminone (CHEBI:73128) has role antineoplastic agent (CHEBI:35610) |
| HPI-1 (CHEBI:231759) has role antineoplastic agent (CHEBI:35610) |
| hydrazinocurcumin (CHEBI:84340) has role antineoplastic agent (CHEBI:35610) |
| hydroxysafflor yellow A (CHEBI:139030) has role antineoplastic agent (CHEBI:35610) |
| hydroxytyrosol (CHEBI:68889) has role antineoplastic agent (CHEBI:35610) |
| hydroxyurea (CHEBI:44423) has role antineoplastic agent (CHEBI:35610) |
| hygrolidin (CHEBI:83959) has role antineoplastic agent (CHEBI:35610) |
| hyperforin (CHEBI:5834) has role antineoplastic agent (CHEBI:35610) |
| hyperxanthone C (CHEBI:66057) has role antineoplastic agent (CHEBI:35610) |
| hyperxanthone E (CHEBI:66058) has role antineoplastic agent (CHEBI:35610) |
| hypocrellin D (CHEBI:66059) has role antineoplastic agent (CHEBI:35610) |
| hypothemycin (CHEBI:83275) has role antineoplastic agent (CHEBI:35610) |
| I-BET151 (CHEBI:95083) has role antineoplastic agent (CHEBI:35610) |
| ibrutinib (CHEBI:76612) has role antineoplastic agent (CHEBI:35610) |
| icariside II (CHEBI:82619) has role antineoplastic agent (CHEBI:35610) |
| ICI-164384 (CHEBI:40710) has role antineoplastic agent (CHEBI:35610) |
| ICRF-193 (CHEBI:93771) has role antineoplastic agent (CHEBI:35610) |
| idelalisib (CHEBI:82701) has role antineoplastic agent (CHEBI:35610) |
| ifosfamide (CHEBI:5864) has role antineoplastic agent (CHEBI:35610) |
| iFSP1 (CHEBI:176501) has role antineoplastic agent (CHEBI:35610) |
| igalan (CHEBI:66068) has role antineoplastic agent (CHEBI:35610) |
| ikarugamycin (CHEBI:75276) has role antineoplastic agent (CHEBI:35610) |
| ilomastat (CHEBI:137236) has role antineoplastic agent (CHEBI:35610) |
| imatinib (CHEBI:45783) has role antineoplastic agent (CHEBI:35610) |
| imatinib methanesulfonate (CHEBI:31690) has role antineoplastic agent (CHEBI:35610) |
| IMID-2 (CHEBI:177369) has role antineoplastic agent (CHEBI:35610) |
| imiquimod (CHEBI:36704) has role antineoplastic agent (CHEBI:35610) |
| indanomycin (CHEBI:141380) has role antineoplastic agent (CHEBI:35610) |
| indirubin (CHEBI:183083) has role antineoplastic agent (CHEBI:35610) |
| indisulam (CHEBI:145431) has role antineoplastic agent (CHEBI:35610) |
| indole-3-methanol (CHEBI:24814) has role antineoplastic agent (CHEBI:35610) |
| INDY (CHEBI:195332) has role antineoplastic agent (CHEBI:35610) |
| ingenol mebutate (CHEBI:66913) has role antineoplastic agent (CHEBI:35610) |
| irilone (CHEBI:5970) has role antineoplastic agent (CHEBI:35610) |
| irinotecan (CHEBI:80630) has role antineoplastic agent (CHEBI:35610) |
| irinotecan hydrochloride (anhydrous) (CHEBI:5971) has role antineoplastic agent (CHEBI:35610) |
| irinotecan hydrochloride hydrate (CHEBI:90881) has role antineoplastic agent (CHEBI:35610) |
| isariotin F (CHEBI:66086) has role antineoplastic agent (CHEBI:35610) |
| isobrucein A (CHEBI:5987) has role antineoplastic agent (CHEBI:35610) |
| isochamuvaritin (CHEBI:66092) has role antineoplastic agent (CHEBI:35610) |
| isoflavipucine (CHEBI:156435) has role antineoplastic agent (CHEBI:35610) |
| isoginkgetin (CHEBI:79087) has role antineoplastic agent (CHEBI:35610) |
| isoiguesterin (CHEBI:66094) has role antineoplastic agent (CHEBI:35610) |
| isoliquiritigenin (CHEBI:310312) has role antineoplastic agent (CHEBI:35610) |
| isoliquiritin (CHEBI:80839) has role antineoplastic agent (CHEBI:35610) |
| isoorientin (CHEBI:17965) has role antineoplastic agent (CHEBI:35610) |
| isorhapontigenin (CHEBI:167830) has role antineoplastic agent (CHEBI:35610) |
| isostrychnine (CHEBI:132659) has role antineoplastic agent (CHEBI:35610) |
| isotretinoin (CHEBI:6067) has role antineoplastic agent (CHEBI:35610) |
| isowigtheone hydrate (CHEBI:66099) has role antineoplastic agent (CHEBI:35610) |
| itarnafloxin (CHEBI:177533) has role antineoplastic agent (CHEBI:35610) |
| iturin A (CHEBI:31737) has role antineoplastic agent (CHEBI:35610) |
| ivosidenib (CHEBI:145430) has role antineoplastic agent (CHEBI:35610) |
| ixabepilone (CHEBI:63605) has role antineoplastic agent (CHEBI:35610) |
| ixazomib (CHEBI:90942) has role antineoplastic agent (CHEBI:35610) |
| ixazomib citrate (CHEBI:90939) has role antineoplastic agent (CHEBI:35610) |
| ixerochinolide (CHEBI:66100) has role antineoplastic agent (CHEBI:35610) |
| jacarelhyperol A (CHEBI:66101) has role antineoplastic agent (CHEBI:35610) |
| jaceosidin (CHEBI:66103) has role antineoplastic agent (CHEBI:35610) |
| jadomycin B (CHEBI:31738) has role antineoplastic agent (CHEBI:35610) |
| jaspamide (CHEBI:66104) has role antineoplastic agent (CHEBI:35610) |
| jaspamide B (CHEBI:66105) has role antineoplastic agent (CHEBI:35610) |
| jaspamide C (CHEBI:66106) has role antineoplastic agent (CHEBI:35610) |
| jaspamide D (CHEBI:66107) has role antineoplastic agent (CHEBI:35610) |
| jaspamide E (CHEBI:66108) has role antineoplastic agent (CHEBI:35610) |
| jaspamide F (CHEBI:66109) has role antineoplastic agent (CHEBI:35610) |
| jaspamide G (CHEBI:66110) has role antineoplastic agent (CHEBI:35610) |
| jaspamide H (CHEBI:66111) has role antineoplastic agent (CHEBI:35610) |
| jaspamide J (CHEBI:66114) has role antineoplastic agent (CHEBI:35610) |
| jaspamide K (CHEBI:66112) has role antineoplastic agent (CHEBI:35610) |
| jaspamide L (CHEBI:66113) has role antineoplastic agent (CHEBI:35610) |
| jaspamide M (CHEBI:66115) has role antineoplastic agent (CHEBI:35610) |
| jaspamide N (CHEBI:66116) has role antineoplastic agent (CHEBI:35610) |
| jaspamide O (CHEBI:66117) has role antineoplastic agent (CHEBI:35610) |
| jaspamide P (CHEBI:66118) has role antineoplastic agent (CHEBI:35610) |
| jasplakinolide D (CHEBI:68271) has role antineoplastic agent (CHEBI:35610) |
| jasplakinolide Q (CHEBI:68272) has role antineoplastic agent (CHEBI:35610) |
| jasplakinolide R1 (CHEBI:68273) has role antineoplastic agent (CHEBI:35610) |
| jerantinine A (CHEBI:66119) has role antineoplastic agent (CHEBI:35610) |
| jerantinine B (CHEBI:66120) has role antineoplastic agent (CHEBI:35610) |
| jerantinine C (CHEBI:66121) has role antineoplastic agent (CHEBI:35610) |
| jerantinine D (CHEBI:66122) has role antineoplastic agent (CHEBI:35610) |
| jerantinine E (CHEBI:66123) has role antineoplastic agent (CHEBI:35610) |
| jerantinine F (CHEBI:66124) has role antineoplastic agent (CHEBI:35610) |
| JHU083 (CHEBI:232049) has role antineoplastic agent (CHEBI:35610) |
| jineol (CHEBI:66125) has role antineoplastic agent (CHEBI:35610) |
| JM335 (CHEBI:85610) has role antineoplastic agent (CHEBI:35610) |
| JP-8g (CHEBI:74654) has role antineoplastic agent (CHEBI:35610) |
| JQ1 (CHEBI:137113) has role antineoplastic agent (CHEBI:35610) |
| JS-K (CHEBI:232953) has role antineoplastic agent (CHEBI:35610) |
| JTE-013 (CHEBI:195541) has role antineoplastic agent (CHEBI:35610) |
| JTE-607 dihydrochloride (CHEBI:167629) has role antineoplastic agent (CHEBI:35610) |
| JTE-607 free base (CHEBI:167630) has role antineoplastic agent (CHEBI:35610) |
| juglanin A (CHEBI:66126) has role antineoplastic agent (CHEBI:35610) |
| juglanin B (CHEBI:66127) has role antineoplastic agent (CHEBI:35610) |
| JWH-133 (CHEBI:146243) has role antineoplastic agent (CHEBI:35610) |
| kadlongilactone A (CHEBI:66128) has role antineoplastic agent (CHEBI:35610) |
| kadlongilactone B (CHEBI:66129) has role antineoplastic agent (CHEBI:35610) |
| kaempferol 3-O-(5-O-acetyl-α-D-apiofuranosyl)-7-O-α-L-rhamnopyranoside (CHEBI:68877) has role antineoplastic agent (CHEBI:35610) |
| kaempferol 3,7-di-O-α-L-rhamnoside (CHEBI:68883) has role antineoplastic agent (CHEBI:35610) |
| kaempferol 7-O-(2-E-p-coumaroyl-α-L-rhamnopyranoside) (CHEBI:66134) has role antineoplastic agent (CHEBI:35610) |
| kaempferol 7-O-(2,3-di-E-p-coumaroyl-α-L-rhamnopyranoside) (CHEBI:66133) has role antineoplastic agent (CHEBI:35610) |
| kahweol (CHEBI:138308) has role antineoplastic agent (CHEBI:35610) |
| kansuiphorin A (CHEBI:66138) has role antineoplastic agent (CHEBI:35610) |
| kansuiphorin B (CHEBI:66139) has role antineoplastic agent (CHEBI:35610) |
| Ki11502 (CHEBI:133397) has role antineoplastic agent (CHEBI:35610) |
| kidjoranin-3-O-α-diginopyranosyl-(1→4)-β-cymaropyranoside (CHEBI:66144) has role antineoplastic agent (CHEBI:35610) |
| kidjoranin-3-O-β-digitoxopyranoside (CHEBI:66145) has role antineoplastic agent (CHEBI:35610) |
| kievitone (CHEBI:16832) has role antineoplastic agent (CHEBI:35610) |
| kinanthraquinone (CHEBI:167575) has role antineoplastic agent (CHEBI:35610) |
| kitastatin 1 (CHEBI:66146) has role antineoplastic agent (CHEBI:35610) |
| knipholone (CHEBI:6141) has role antineoplastic agent (CHEBI:35610) |
| koshikamide A2 (CHEBI:66149) has role antineoplastic agent (CHEBI:35610) |
| KP1019 (CHEBI:77760) has role antineoplastic agent (CHEBI:35610) |
| KP1339 (CHEBI:176975) has role antineoplastic agent (CHEBI:35610) |
| KRIBB11 (CHEBI:228800) has role antineoplastic agent (CHEBI:35610) |
| Ku-0063794 (CHEBI:85572) has role antineoplastic agent (CHEBI:35610) |
| KU-55933 (CHEBI:228209) has role antineoplastic agent (CHEBI:35610) |
| KU-60019 (CHEBI:228206) has role antineoplastic agent (CHEBI:35610) |
| kweichowenol B (CHEBI:66152) has role antineoplastic agent (CHEBI:35610) |
| L-744,832 (CHEBI:183636) has role antineoplastic agent (CHEBI:35610) |
| L-778,123 (free base) (CHEBI:180478) has role antineoplastic agent (CHEBI:35610) |
| L-778,123 hydrochloride (CHEBI:177371) has role antineoplastic agent (CHEBI:35610) |
| lanperisone (CHEBI:176339) has role antineoplastic agent (CHEBI:35610) |
| lanperisone hydrochloride (CHEBI:31762) has role antineoplastic agent (CHEBI:35610) |
| lanthanum trichloride (CHEBI:231515) has role antineoplastic agent (CHEBI:35610) |
| lapachol (CHEBI:6377) has role antineoplastic agent (CHEBI:35610) |
| lapatinib (CHEBI:49603) has role antineoplastic agent (CHEBI:35610) |
| lasofoxifene (CHEBI:135938) has role antineoplastic agent (CHEBI:35610) |
| laulimalide (CHEBI:69134) has role antineoplastic agent (CHEBI:35610) |
| laurebiphenyl (CHEBI:66554) has role antineoplastic agent (CHEBI:35610) |
| LB42908 (CHEBI:167660) has role antineoplastic agent (CHEBI:35610) |
| LCL161 (CHEBI:193137) has role antineoplastic agent (CHEBI:35610) |
| LDC4297 (CHEBI:144671) has role antineoplastic agent (CHEBI:35610) |
| LDN-212854 (CHEBI:229962) has role antineoplastic agent (CHEBI:35610) |
| leachianone A (CHEBI:66559) has role antineoplastic agent (CHEBI:35610) |
| leflunomide (CHEBI:6402) has role antineoplastic agent (CHEBI:35610) |
| lehualide F (CHEBI:68006) has role antineoplastic agent (CHEBI:35610) |
| lehualide G (CHEBI:68007) has role antineoplastic agent (CHEBI:35610) |
| lehualide H (CHEBI:68008) has role antineoplastic agent (CHEBI:35610) |
| lehualide I (CHEBI:68009) has role antineoplastic agent (CHEBI:35610) |
| lejimalide A (CHEBI:77757) has role antineoplastic agent (CHEBI:35610) |
| lejimalide B (CHEBI:77759) has role antineoplastic agent (CHEBI:35610) |
| lenalidomide (CHEBI:63791) has role antineoplastic agent (CHEBI:35610) |
| lentinan (CHEBI:31770) has role antineoplastic agent (CHEBI:35610) |
| lenvatinib (CHEBI:85994) has role antineoplastic agent (CHEBI:35610) |
| lenvatinib mesylate (CHEBI:85995) has role antineoplastic agent (CHEBI:35610) |
| letrozole (CHEBI:6413) has role antineoplastic agent (CHEBI:35610) |
| leucospiroside A (CHEBI:66574) has role antineoplastic agent (CHEBI:35610) |
| leuprolide (CHEBI:6427) has role antineoplastic agent (CHEBI:35610) |
| leuprolide acetate (CHEBI:63597) has role antineoplastic agent (CHEBI:35610) |
| LFM-A13 (CHEBI:183517) has role antineoplastic agent (CHEBI:35610) |
| licofelone (CHEBI:47532) has role antineoplastic agent (CHEBI:35610) |
| lificiguat (CHEBI:142430) has role antineoplastic agent (CHEBI:35610) |
| ligstroside (CHEBI:149585) has role antineoplastic agent (CHEBI:35610) |
| linifanib (CHEBI:91435) has role antineoplastic agent (CHEBI:35610) |
| linsitinib (CHEBI:91402) has role antineoplastic agent (CHEBI:35610) |
| liriodenine (CHEBI:70649) has role antineoplastic agent (CHEBI:35610) |
| lissoclibadin 1 (CHEBI:66579) has role antineoplastic agent (CHEBI:35610) |
| lissoclibadin 2 (CHEBI:66580) has role antineoplastic agent (CHEBI:35610) |
| lissoclibadin 3 (CHEBI:66581) has role antineoplastic agent (CHEBI:35610) |
| LLP-3 (CHEBI:78766) has role antineoplastic agent (CHEBI:35610) |
| lobaplatin (CHEBI:192744) has role antineoplastic agent (CHEBI:35610) |
| lomustine (CHEBI:6520) has role antineoplastic agent (CHEBI:35610) |
| lonafarnib (CHEBI:47097) has role antineoplastic agent (CHEBI:35610) |
| lonazolac (CHEBI:76164) has role antineoplastic agent (CHEBI:35610) |
| lonazolac calcium (CHEBI:76167) has role antineoplastic agent (CHEBI:35610) |
| longicalycinin A (CHEBI:66590) has role antineoplastic agent (CHEBI:35610) |
| longirostrerone A (CHEBI:68980) has role antineoplastic agent (CHEBI:35610) |
| longirostrerone B (CHEBI:68981) has role antineoplastic agent (CHEBI:35610) |
| longirostrerone C (CHEBI:68982) has role antineoplastic agent (CHEBI:35610) |
| longirostrerone D (CHEBI:68774) has role antineoplastic agent (CHEBI:35610) |
| lonidamine (CHEBI:50138) has role antineoplastic agent (CHEBI:35610) |
| Lonsurf (CHEBI:90876) has role antineoplastic agent (CHEBI:35610) |
| lorlatinib (CHEBI:143117) has role antineoplastic agent (CHEBI:35610) |
| lovastatin (CHEBI:40303) has role antineoplastic agent (CHEBI:35610) |
| LRRK2-IN-1 (CHEBI:78413) has role antineoplastic agent (CHEBI:35610) |
| lucanthone (CHEBI:51052) has role antineoplastic agent (CHEBI:35610) |
| lucialdehyde B (CHEBI:66593) has role antineoplastic agent (CHEBI:35610) |
| lucialdehyde C (CHEBI:66594) has role antineoplastic agent (CHEBI:35610) |
| lucidenic acid N (CHEBI:66595) has role antineoplastic agent (CHEBI:35610) |
| luminespib (CHEBI:83656) has role antineoplastic agent (CHEBI:35610) |
| lunasine (CHEBI:233245) has role antineoplastic agent (CHEBI:35610) |
| lupulone (CHEBI:6574) has role antineoplastic agent (CHEBI:35610) |
| lurbinectedin (CHEBI:746908) has role antineoplastic agent (CHEBI:35610) |
| luteolin (CHEBI:15864) has role antineoplastic agent (CHEBI:35610) |
| luzonial A (CHEBI:66598) has role antineoplastic agent (CHEBI:35610) |
| luzonial B (CHEBI:66599) has role antineoplastic agent (CHEBI:35610) |
| luzonidial B (CHEBI:66600) has role antineoplastic agent (CHEBI:35610) |
| LY-2090314 (CHEBI:167661) has role antineoplastic agent (CHEBI:35610) |
| LY-2157299 (CHEBI:137064) has role antineoplastic agent (CHEBI:35610) |
| LY3009120 (CHEBI:167662) has role antineoplastic agent (CHEBI:35610) |
| lychnostatin 1 (CHEBI:66601) has role antineoplastic agent (CHEBI:35610) |
| lychnostatin 2 (CHEBI:66602) has role antineoplastic agent (CHEBI:35610) |
| lyratol C (CHEBI:66607) has role antineoplastic agent (CHEBI:35610) |
| lyratol D (CHEBI:66608) has role antineoplastic agent (CHEBI:35610) |
| lysikokianoside 1 (CHEBI:69611) has role antineoplastic agent (CHEBI:35610) |
| maackiaflavanone A (CHEBI:66643) has role antineoplastic agent (CHEBI:35610) |
| maackiaflavanone B (CHEBI:66644) has role antineoplastic agent (CHEBI:35610) |
| maackiapterocarpan A (CHEBI:66645) has role antineoplastic agent (CHEBI:35610) |
| macaflavanone G (CHEBI:66647) has role antineoplastic agent (CHEBI:35610) |
| macaranone A (CHEBI:66648) has role antineoplastic agent (CHEBI:35610) |
| macluraxanthone B (CHEBI:66649) has role antineoplastic agent (CHEBI:35610) |
| macluraxanthone C (CHEBI:66650) has role antineoplastic agent (CHEBI:35610) |
| madecassic acid (CHEBI:73058) has role antineoplastic agent (CHEBI:35610) |
| manassantin A (CHEBI:66663) has role antineoplastic agent (CHEBI:35610) |
| manassantin B (CHEBI:66664) has role antineoplastic agent (CHEBI:35610) |
| manool (CHEBI:76945) has role antineoplastic agent (CHEBI:35610) |
| manumycin A (CHEBI:29623) has role antineoplastic agent (CHEBI:35610) |
| manzamine A (CHEBI:66667) has role antineoplastic agent (CHEBI:35610) |
| maoecrystal Z (CHEBI:66670) has role antineoplastic agent (CHEBI:35610) |
| marimastat (CHEBI:50662) has role antineoplastic agent (CHEBI:35610) |
| marineosin A (CHEBI:66676) has role antineoplastic agent (CHEBI:35610) |
| marineosin B (CHEBI:66677) has role antineoplastic agent (CHEBI:35610) |
| masitinib (CHEBI:63450) has role antineoplastic agent (CHEBI:35610) |
| maslinic acid (CHEBI:66682) has role antineoplastic agent (CHEBI:35610) |
| masoprocol (CHEBI:73468) has role antineoplastic agent (CHEBI:35610) |
| maytansine (CHEBI:6701) has role antineoplastic agent (CHEBI:35610) |
| maytenfolone A (CHEBI:66686) has role antineoplastic agent (CHEBI:35610) |
| MCB-613 (CHEBI:90954) has role antineoplastic agent (CHEBI:35610) |
| mechlorethamine hydrochloride (CHEBI:55368) has role antineoplastic agent (CHEBI:35610) |
| meclofenamic acid (CHEBI:6710) has role antineoplastic agent (CHEBI:35610) |
| medroxyprogesterone acetate (CHEBI:6716) has role antineoplastic agent (CHEBI:35610) |
| mefuparib (CHEBI:167905) has role antineoplastic agent (CHEBI:35610) |
| mefuparib hydrochloride (CHEBI:167899) has role antineoplastic agent (CHEBI:35610) |
| megathyrin A (CHEBI:66689) has role antineoplastic agent (CHEBI:35610) |
| megestrol (CHEBI:6722) has role antineoplastic agent (CHEBI:35610) |
| megestrol acetate (CHEBI:6723) has role antineoplastic agent (CHEBI:35610) |
| melittin (CHEBI:6736) has role antineoplastic agent (CHEBI:35610) |
| melophlin P (CHEBI:66691) has role antineoplastic agent (CHEBI:35610) |
| melophlin Q (CHEBI:66692) has role antineoplastic agent (CHEBI:35610) |
| melophlin R (CHEBI:66693) has role antineoplastic agent (CHEBI:35610) |
| melophlin S (CHEBI:66694) has role antineoplastic agent (CHEBI:35610) |
| melphalan (CHEBI:28876) has role antineoplastic agent (CHEBI:35610) |
| menadione (CHEBI:28869) has role antineoplastic agent (CHEBI:35610) |
| mercaptopurine (CHEBI:50667) has role antineoplastic agent (CHEBI:35610) |
| mertansine (CHEBI:82755) has role antineoplastic agent (CHEBI:35610) |
| Met-enkephalin (CHEBI:6618) has role antineoplastic agent (CHEBI:35610) |
| metachromin S (CHEBI:66695) has role antineoplastic agent (CHEBI:35610) |
| metachromin T (CHEBI:66696) has role antineoplastic agent (CHEBI:35610) |
| metholone (CHEBI:34838) has role antineoplastic agent (CHEBI:35610) |
| methotrexate (CHEBI:44185) has role antineoplastic agent (CHEBI:35610) |
| methoxsalen (CHEBI:18358) has role antineoplastic agent (CHEBI:35610) |
| methoxyacetic acid (CHEBI:132098) has role antineoplastic agent (CHEBI:35610) |
| methyl (indol-3-yl)acetate (CHEBI:72782) has role antineoplastic agent (CHEBI:35610) |
| methyl 5-aminolevulinate (CHEBI:724125) has role antineoplastic agent (CHEBI:35610) |
| methyl 5-aminolevulinate hydrochloride (CHEBI:60641) has role antineoplastic agent (CHEBI:35610) |
| Methyl violet 2B (CHEBI:90108) has role antineoplastic agent (CHEBI:35610) |
| Methyl violet 2B free base (CHEBI:90110) has role antineoplastic agent (CHEBI:35610) |
| methyl γ-linolenate (CHEBI:144354) has role antineoplastic agent (CHEBI:35610) |
| methyllinderone (CHEBI:233555) has role antineoplastic agent (CHEBI:35610) |
| methylseleninic acid (CHEBI:77012) has role antineoplastic agent (CHEBI:35610) |
| methylselenol (CHEBI:64685) has role antineoplastic agent (CHEBI:35610) |
| methylstat (CHEBI:95078) has role antineoplastic agent (CHEBI:35610) |
| methyltestosterone (CHEBI:27436) has role antineoplastic agent (CHEBI:35610) |
| methylthioadenosine-DADMe immucillin-A (CHEBI:234322) has role antineoplastic agent (CHEBI:35610) |
| miboplatin (CHEBI:36143) has role antineoplastic agent (CHEBI:35610) |
| michaolide A (CHEBI:66374) has role antineoplastic agent (CHEBI:35610) |
| michaolide B (CHEBI:66375) has role antineoplastic agent (CHEBI:35610) |
| michaolide C (CHEBI:66376) has role antineoplastic agent (CHEBI:35610) |
| michaolide D (CHEBI:66377) has role antineoplastic agent (CHEBI:35610) |
| michaolide E (CHEBI:66378) has role antineoplastic agent (CHEBI:35610) |
| michaolide F (CHEBI:66379) has role antineoplastic agent (CHEBI:35610) |
| michaolide G (CHEBI:66380) has role antineoplastic agent (CHEBI:35610) |
| michaolide H (CHEBI:66381) has role antineoplastic agent (CHEBI:35610) |
| michaolide I (CHEBI:66382) has role antineoplastic agent (CHEBI:35610) |
| michaolide J (CHEBI:66383) has role antineoplastic agent (CHEBI:35610) |
| michaolide K (CHEBI:66384) has role antineoplastic agent (CHEBI:35610) |
| miconazole (CHEBI:6923) has role antineoplastic agent (CHEBI:35610) |
| miconazole nitrate (CHEBI:6924) has role antineoplastic agent (CHEBI:35610) |
| microclavatin (CHEBI:66387) has role antineoplastic agent (CHEBI:35610) |
| midazolam (CHEBI:6931) has role antineoplastic agent (CHEBI:35610) |
| midazolam hydrochloride (CHEBI:6932) has role antineoplastic agent (CHEBI:35610) |
| midostaurin (CHEBI:63452) has role antineoplastic agent (CHEBI:35610) |
| migrastatin (CHEBI:66389) has role antineoplastic agent (CHEBI:35610) |
| miltefosine (CHEBI:75283) has role antineoplastic agent (CHEBI:35610) |
| minabeolide 1 (CHEBI:67566) has role antineoplastic agent (CHEBI:35610) |
| minheryin G (CHEBI:66394) has role antineoplastic agent (CHEBI:35610) |
| minquartynoic acid (CHEBI:542606) has role antineoplastic agent (CHEBI:35610) |
| mithramycin (CHEBI:31856) has role antineoplastic agent (CHEBI:35610) |
| mitoguazone (CHEBI:43996) has role antineoplastic agent (CHEBI:35610) |
| mitoguazone hydrochloride (CHEBI:78028) has role antineoplastic agent (CHEBI:35610) |
| mitoguazone hydrochloride hydrate (CHEBI:78032) has role antineoplastic agent (CHEBI:35610) |
| mitomycin A (CHEBI:85412) has role antineoplastic agent (CHEBI:35610) |
| mitomycin B (CHEBI:85416) has role antineoplastic agent (CHEBI:35610) |
| mitomycin C (CHEBI:27504) has role antineoplastic agent (CHEBI:35610) |
| mitoxantrone (CHEBI:50729) has role antineoplastic agent (CHEBI:35610) |
| mitoxantrone dihydrochloride (CHEBI:50727) has role antineoplastic agent (CHEBI:35610) |
| MK-2206 (CHEBI:67271) has role antineoplastic agent (CHEBI:35610) |
| MK-2461 (CHEBI:230540) has role antineoplastic agent (CHEBI:35610) |
| MK-8353 (CHEBI:167664) has role antineoplastic agent (CHEBI:35610) |
| ML-210 (CHEBI:176502) has role antineoplastic agent (CHEBI:35610) |
| ML240 (CHEBI:143014) has role antineoplastic agent (CHEBI:35610) |
| MMP-9-IN-1 (CHEBI:156264) has role antineoplastic agent (CHEBI:35610) |
| mocetinostat (CHEBI:197437) has role antineoplastic agent (CHEBI:35610) |
| mogrol (CHEBI:138974) has role antineoplastic agent (CHEBI:35610) |
| molibresib (CHEBI:95082) has role antineoplastic agent (CHEBI:35610) |
| mollicellin B (CHEBI:68801) has role antineoplastic agent (CHEBI:35610) |
| mollicellin C (CHEBI:68802) has role antineoplastic agent (CHEBI:35610) |
| mollicellin E (CHEBI:68803) has role antineoplastic agent (CHEBI:35610) |
| mollicellin F (CHEBI:68721) has role antineoplastic agent (CHEBI:35610) |
| mollicellin H (CHEBI:68722) has role antineoplastic agent (CHEBI:35610) |
| mollicellin J (CHEBI:68723) has role antineoplastic agent (CHEBI:35610) |
| mollicellin K (CHEBI:68724) has role antineoplastic agent (CHEBI:35610) |
| mollicellin L (CHEBI:68725) has role antineoplastic agent (CHEBI:35610) |
| mollicellin M (CHEBI:68726) has role antineoplastic agent (CHEBI:35610) |
| mollicellin N (CHEBI:68727) has role antineoplastic agent (CHEBI:35610) |
| momelotinib (CHEBI:91407) has role antineoplastic agent (CHEBI:35610) |
| monascin (CHEBI:82621) has role antineoplastic agent (CHEBI:35610) |
| monascorubrin (CHEBI:156408) has role antineoplastic agent (CHEBI:35610) |
| monastrol (CHEBI:75382) has role antineoplastic agent (CHEBI:35610) |
| monodictyochromone A (CHEBI:66396) has role antineoplastic agent (CHEBI:35610) |
| monodictyochromone B (CHEBI:66397) has role antineoplastic agent (CHEBI:35610) |
| monodictysin B (CHEBI:66398) has role antineoplastic agent (CHEBI:35610) |
| monodictysin C (CHEBI:66399) has role antineoplastic agent (CHEBI:35610) |
| morellic acid (CHEBI:66401) has role antineoplastic agent (CHEBI:35610) |
| morellin (CHEBI:6995) has role antineoplastic agent (CHEBI:35610) |
| morin (CHEBI:75092) has role antineoplastic agent (CHEBI:35610) |
| moromycin A (CHEBI:66403) has role antineoplastic agent (CHEBI:35610) |
| moromycin B (CHEBI:66404) has role antineoplastic agent (CHEBI:35610) |
| morusin (CHEBI:7005) has role antineoplastic agent (CHEBI:35610) |
| motixafortide (CHEBI:145536) has role antineoplastic agent (CHEBI:35610) |
| motixafortide acetate (CHEBI:229224) has role antineoplastic agent (CHEBI:35610) |
| MP-A08 (CHEBI:167665) has role antineoplastic agent (CHEBI:35610) |
| MRTX1133 (CHEBI:746962) has role antineoplastic agent (CHEBI:35610) |
| MST-312 (CHEBI:95003) has role antineoplastic agent (CHEBI:35610) |
| MTIC (CHEBI:72568) has role antineoplastic agent (CHEBI:35610) |
| mucronulatol (CHEBI:7014) has role antineoplastic agent (CHEBI:35610) |
| mycophenolic acid (CHEBI:168396) has role antineoplastic agent (CHEBI:35610) |
| myriaporone 3 (CHEBI:66422) has role antineoplastic agent (CHEBI:35610) |
| Myricanone (CHEBI:141540) has role antineoplastic agent (CHEBI:35610) |
| myricetin (CHEBI:18152) has role antineoplastic agent (CHEBI:35610) |
| myriocin (CHEBI:582124) has role antineoplastic agent (CHEBI:35610) |
| myrsinoic acid A (CHEBI:66426) has role antineoplastic agent (CHEBI:35610) |
| naphthazarin (CHEBI:28849) has role antineoplastic agent (CHEBI:35610) |
| naringin (CHEBI:28819) has role antineoplastic agent (CHEBI:35610) |
| nataloe-emodin (CHEBI:152054) has role antineoplastic agent (CHEBI:35610) |
| navitoclax (CHEBI:131174) has role antineoplastic agent (CHEBI:35610) |
| NCX-4040 (CHEBI:233566) has role antineoplastic agent (CHEBI:35610) |
| nelarabine (CHEBI:63612) has role antineoplastic agent (CHEBI:35610) |
| nelfinavir (CHEBI:7496) has role antineoplastic agent (CHEBI:35610) |
| nelfinavir mesylate (CHEBI:7497) has role antineoplastic agent (CHEBI:35610) |
| neobavaisoflavone (CHEBI:66614) has role antineoplastic agent (CHEBI:35610) |
| neocarzinostatin chromophore (CHEBI:29655) has role antineoplastic agent (CHEBI:35610) |
| neohesperidin (CHEBI:59016) has role antineoplastic agent (CHEBI:35610) |
| neratinib (CHEBI:61397) has role antineoplastic agent (CHEBI:35610) |
| nidulalin A (CHEBI:66625) has role antineoplastic agent (CHEBI:35610) |
| nigerapyrone B (CHEBI:69257) has role antineoplastic agent (CHEBI:35610) |
| nigerapyrone D (CHEBI:69259) has role antineoplastic agent (CHEBI:35610) |
| nigerapyrone E (CHEBI:69260) has role antineoplastic agent (CHEBI:35610) |
| nigranoic acid (CHEBI:66626) has role antineoplastic agent (CHEBI:35610) |
| nilotinib (CHEBI:52172) has role antineoplastic agent (CHEBI:35610) |
| nilutamide (CHEBI:7573) has role antineoplastic agent (CHEBI:35610) |
| nimustine (CHEBI:75270) has role antineoplastic agent (CHEBI:35610) |
| nimustine hydrochloride (CHEBI:7576) has role antineoplastic agent (CHEBI:35610) |
| nintedanib (CHEBI:85164) has role antineoplastic agent (CHEBI:35610) |
| nintedanib esylate (CHEBI:85170) has role antineoplastic agent (CHEBI:35610) |
| niraparib (CHEBI:176844) has role antineoplastic agent (CHEBI:35610) |
| nirogacestat (CHEBI:229217) has role antineoplastic agent (CHEBI:35610) |
| nirogacestat dihydrobromide (CHEBI:229218) has role antineoplastic agent (CHEBI:35610) |
| nitensidine E (CHEBI:66628) has role antineoplastic agent (CHEBI:35610) |
| nitrosulindac (CHEBI:75321) has role antineoplastic agent (CHEBI:35610) |
| NK154183A (CHEBI:66629) has role antineoplastic agent (CHEBI:35610) |
| NK154183B (CHEBI:66630) has role antineoplastic agent (CHEBI:35610) |
| NNC 55-0396 (free base) (CHEBI:194337) has role antineoplastic agent (CHEBI:35610) |
| NNC 55-0396 dihydrochloride (CHEBI:194301) has role antineoplastic agent (CHEBI:35610) |
| nobiletin (CHEBI:7602) has role antineoplastic agent (CHEBI:35610) |
| nocodazole (CHEBI:34892) has role antineoplastic agent (CHEBI:35610) |
| nogalamycin (CHEBI:44504) has role antineoplastic agent (CHEBI:35610) |
| nomilin (CHEBI:7609) has role antineoplastic agent (CHEBI:35610) |
| nonanedioic acid (CHEBI:48131) has role antineoplastic agent (CHEBI:35610) |
| norathyriol (CHEBI:7622) has role antineoplastic agent (CHEBI:35610) |
| nortriptyline (CHEBI:7640) has role antineoplastic agent (CHEBI:35610) |
| NS-398 (CHEBI:73458) has role antineoplastic agent (CHEBI:35610) |
| numidargistat (CHEBI:195556) has role antineoplastic agent (CHEBI:35610) |
| Nutlin (CHEBI:46741) has role antineoplastic agent (CHEBI:35610) |
| obochalcolactone (CHEBI:66802) has role antineoplastic agent (CHEBI:35610) |
| obolactone (CHEBI:66803) has role antineoplastic agent (CHEBI:35610) |
| obyanamide (CHEBI:66805) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin A (CHEBI:66811) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin B (CHEBI:66812) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin C (CHEBI:66813) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin D (CHEBI:66814) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin E (CHEBI:66815) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin F (CHEBI:66816) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpin G (CHEBI:66817) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpinone A (CHEBI:66808) has role antineoplastic agent (CHEBI:35610) |
| ochrocarpinone B (CHEBI:66809) has role antineoplastic agent (CHEBI:35610) |
| olaparib (CHEBI:83766) has role antineoplastic agent (CHEBI:35610) |
| oleanolic acid 3-O-[O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→3)-O-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranoside] (CHEBI:66818) has role antineoplastic agent (CHEBI:35610) |
| oleocanthal (CHEBI:85673) has role antineoplastic agent (CHEBI:35610) |
| oleuropein (CHEBI:7747) has role antineoplastic agent (CHEBI:35610) |
| oligomycin A (CHEBI:28285) has role antineoplastic agent (CHEBI:35610) |
| oligomycin D (CHEBI:7753) has role antineoplastic agent (CHEBI:35610) |
| oltipraz (CHEBI:77319) has role antineoplastic agent (CHEBI:35610) |
| omacetaxine mepesuccinate (CHEBI:71019) has role antineoplastic agent (CHEBI:35610) |
| omaveloxolone (CHEBI:229661) has role antineoplastic agent (CHEBI:35610) |
| omipalisib (CHEBI:95093) has role antineoplastic agent (CHEBI:35610) |
| onalespib (CHEBI:140592) has role antineoplastic agent (CHEBI:35610) |
| oncrasin-1 (CHEBI:178196) has role antineoplastic agent (CHEBI:35610) |
| ophiobolin C (CHEBI:167548) has role antineoplastic agent (CHEBI:35610) |
| orantinib (CHEBI:91088) has role antineoplastic agent (CHEBI:35610) |
| orbiculin A (CHEBI:66824) has role antineoplastic agent (CHEBI:35610) |
| orbiculin E (CHEBI:66826) has role antineoplastic agent (CHEBI:35610) |
| orbiculin F (CHEBI:66827) has role antineoplastic agent (CHEBI:35610) |
| orbiculin G (CHEBI:66828) has role antineoplastic agent (CHEBI:35610) |
| oridonin (CHEBI:138236) has role antineoplastic agent (CHEBI:35610) |
| ormaplatin (CHEBI:85577) has role antineoplastic agent (CHEBI:35610) |
| oroxylin A (CHEBI:61668) has role antineoplastic agent (CHEBI:35610) |
| oroxylin A(1−) (CHEBI:77939) has role antineoplastic agent (CHEBI:35610) |
| orteronel (CHEBI:231353) has role antineoplastic agent (CHEBI:35610) |
| osimertinib (CHEBI:90943) has role antineoplastic agent (CHEBI:35610) |
| osimertinib mesylate (CHEBI:90948) has role antineoplastic agent (CHEBI:35610) |
| ospemifene (CHEBI:73275) has role antineoplastic agent (CHEBI:35610) |
| ossamycin (CHEBI:77735) has role antineoplastic agent (CHEBI:35610) |
| OSU-03012 (CHEBI:131196) has role antineoplastic agent (CHEBI:35610) |
| oviedomycin (CHEBI:156291) has role antineoplastic agent (CHEBI:35610) |
| oxaline (CHEBI:70400) has role antineoplastic agent (CHEBI:35610) |
| oxaliplatin (CHEBI:31941) has role antineoplastic agent (CHEBI:35610) |
| oxypeucedanin hydrate acetonide (CHEBI:66843) has role antineoplastic agent (CHEBI:35610) |
| oxyphenbutazone (CHEBI:76258) has role antineoplastic agent (CHEBI:35610) |
| oxyphenbutazone hydrate (CHEBI:76259) has role antineoplastic agent (CHEBI:35610) |
| PABA/NO (CHEBI:195533) has role antineoplastic agent (CHEBI:35610) |
| paclitaxel (CHEBI:45863) has role antineoplastic agent (CHEBI:35610) |
| pacritinib (CHEBI:231350) has role antineoplastic agent (CHEBI:35610) |
| pacritinib citrate (CHEBI:231412) has role antineoplastic agent (CHEBI:35610) |
| palau'amide (CHEBI:66721) has role antineoplastic agent (CHEBI:35610) |
| palbociclib (CHEBI:85993) has role antineoplastic agent (CHEBI:35610) |
| pannarin (CHEBI:144185) has role antineoplastic agent (CHEBI:35610) |
| panobinostat (CHEBI:85990) has role antineoplastic agent (CHEBI:35610) |
| panobinostat lactate (CHEBI:85991) has role antineoplastic agent (CHEBI:35610) |
| papuamide B (CHEBI:83265) has role antineoplastic agent (CHEBI:35610) |
| paraminabeolide A (CHEBI:67560) has role antineoplastic agent (CHEBI:35610) |
| parbendazole (CHEBI:94267) has role antineoplastic agent (CHEBI:35610) |
| pasireotide (CHEBI:72312) has role antineoplastic agent (CHEBI:35610) |
| pasireotide aspartate (CHEBI:72313) has role antineoplastic agent (CHEBI:35610) |
| pateamine (CHEBI:134184) has role antineoplastic agent (CHEBI:35610) |
| pazopanib (CHEBI:71219) has role antineoplastic agent (CHEBI:35610) |
| pazopanib hydrochloride (CHEBI:71217) has role antineoplastic agent (CHEBI:35610) |
| PB28 (CHEBI:189648) has role antineoplastic agent (CHEBI:35610) |
| PD 0325901 (CHEBI:88249) has role antineoplastic agent (CHEBI:35610) |
| PD-166866 (CHEBI:156259) has role antineoplastic agent (CHEBI:35610) |
| PD158780 (CHEBI:92843) has role antineoplastic agent (CHEBI:35610) |
| PD173074 (CHEBI:63448) has role antineoplastic agent (CHEBI:35610) |
| pectolinarin (CHEBI:156327) has role antineoplastic agent (CHEBI:35610) |
| pederin (CHEBI:78591) has role antineoplastic agent (CHEBI:35610) |
| pelabresib (CHEBI:189653) has role antineoplastic agent (CHEBI:35610) |
| peloruside A (CHEBI:77692) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed (CHEBI:63616) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed disodium (CHEBI:63722) has role antineoplastic agent (CHEBI:35610) |
| pemetrexed disodium heptahydrate (CHEBI:63723) has role antineoplastic agent (CHEBI:35610) |
| pentostatin (CHEBI:27834) has role antineoplastic agent (CHEBI:35610) |
| peonidin (CHEBI:75314) has role antineoplastic agent (CHEBI:35610) |
| peonidin chloride (CHEBI:75033) has role antineoplastic agent (CHEBI:35610) |
| perillic acid (CHEBI:36999) has role antineoplastic agent (CHEBI:35610) |
| pevonedistat (CHEBI:145535) has role antineoplastic agent (CHEBI:35610) |
| pexidartinib (CHEBI:145373) has role antineoplastic agent (CHEBI:35610) |
| PF-00477736 (CHEBI:91385) has role antineoplastic agent (CHEBI:35610) |
| PF-06409577 (CHEBI:231658) has role antineoplastic agent (CHEBI:35610) |
| PF-3758309 (CHEBI:93751) has role antineoplastic agent (CHEBI:35610) |
| PF-573228 (CHEBI:91446) has role antineoplastic agent (CHEBI:35610) |
| PHA-533533 (CHEBI:132239) has role antineoplastic agent (CHEBI:35610) |
| PHA-665752 (CHEBI:90197) has role antineoplastic agent (CHEBI:35610) |
| phantomolin (CHEBI:8041) has role antineoplastic agent (CHEBI:35610) |
| phaseolotoxin (CHEBI:8047) has role antineoplastic agent (CHEBI:35610) |
| phenethyl caffeate (CHEBI:8062) has role antineoplastic agent (CHEBI:35610) |
| phenethyl isothiocyanate (CHEBI:351346) has role antineoplastic agent (CHEBI:35610) |
| phenformin (CHEBI:8064) has role antineoplastic agent (CHEBI:35610) |
| phenylarsine oxide (CHEBI:75253) has role antineoplastic agent (CHEBI:35610) |
| phleomycin (CHEBI:75044) has role antineoplastic agent (CHEBI:35610) |
| phleomycin D1 (CHEBI:75046) has role antineoplastic agent (CHEBI:35610) |
| phloretin (CHEBI:17276) has role antineoplastic agent (CHEBI:35610) |
| phomacin A (CHEBI:66746) has role antineoplastic agent (CHEBI:35610) |
| phomacin B (CHEBI:66747) has role antineoplastic agent (CHEBI:35610) |
| phomacin C (CHEBI:66748) has role antineoplastic agent (CHEBI:35610) |
| phomoxanthone A (CHEBI:66749) has role antineoplastic agent (CHEBI:35610) |
| phomoxanthone B (CHEBI:66750) has role antineoplastic agent (CHEBI:35610) |
| phorbol 13-acetate 12-myristate (CHEBI:37537) has role antineoplastic agent (CHEBI:35610) |
| physalin B (CHEBI:69017) has role antineoplastic agent (CHEBI:35610) |
| physalin D (CHEBI:69018) has role antineoplastic agent (CHEBI:35610) |
| physalin F (CHEBI:69019) has role antineoplastic agent (CHEBI:35610) |
| physcion (CHEBI:38167) has role antineoplastic agent (CHEBI:35610) |
| PI-103 (CHEBI:90524) has role antineoplastic agent (CHEBI:35610) |
| piceatannol (CHEBI:28814) has role antineoplastic agent (CHEBI:35610) |
| picropodophyllotoxin (CHEBI:75251) has role antineoplastic agent (CHEBI:35610) |
| pierreione A (CHEBI:68047) has role antineoplastic agent (CHEBI:35610) |
| pierreione B (CHEBI:68048) has role antineoplastic agent (CHEBI:35610) |
| pimasertib (CHEBI:94793) has role antineoplastic agent (CHEBI:35610) |
| pinocembrin (CHEBI:28157) has role antineoplastic agent (CHEBI:35610) |
| pipobroman (CHEBI:8242) has role antineoplastic agent (CHEBI:35610) |
| pirarubicin (CHEBI:94770) has role antineoplastic agent (CHEBI:35610) |
| pirazofurin (CHEBI:90284) has role antineoplastic agent (CHEBI:35610) |
| pirtobrutinib (CHEBI:229212) has role antineoplastic agent (CHEBI:35610) |
| PJ34 (CHEBI:167900) has role antineoplastic agent (CHEBI:35610) |
| PJ34 hydrochloride (CHEBI:167904) has role antineoplastic agent (CHEBI:35610) |
| PK-11195 (CHEBI:73290) has role antineoplastic agent (CHEBI:35610) |
| plaunotol (CHEBI:32023) has role antineoplastic agent (CHEBI:35610) |
| pleosporone (CHEBI:66765) has role antineoplastic agent (CHEBI:35610) |
| plerixafor (CHEBI:125354) has role antineoplastic agent (CHEBI:35610) |
| plinabulin (CHEBI:177413) has role antineoplastic agent (CHEBI:35610) |
| plitidepsin (CHEBI:90205) has role antineoplastic agent (CHEBI:35610) |
| PLS-123 (CHEBI:230531) has role antineoplastic agent (CHEBI:35610) |
| plumbagin (CHEBI:8273) has role antineoplastic agent (CHEBI:35610) |
| PLX-4720 (CHEBI:90295) has role antineoplastic agent (CHEBI:35610) |
| PM-94128 (CHEBI:66766) has role antineoplastic agent (CHEBI:35610) |
| PM00104 (CHEBI:235523) has role antineoplastic agent (CHEBI:35610) |
| podophyllotoxin (CHEBI:50305) has role antineoplastic agent (CHEBI:35610) |
| polyketomycin (CHEBI:66771) has role antineoplastic agent (CHEBI:35610) |
| pomalidomide (CHEBI:72690) has role antineoplastic agent (CHEBI:35610) |
| ponatinib (CHEBI:78543) has role antineoplastic agent (CHEBI:35610) |
| ponatinib hydrochloride (CHEBI:191940) has role antineoplastic agent (CHEBI:35610) |
| porfimer (CHEBI:60652) has role antineoplastic agent (CHEBI:35610) |
| porfimer sodium (CHEBI:60773) has role antineoplastic agent (CHEBI:35610) |
| poziotinib (CHEBI:195559) has role antineoplastic agent (CHEBI:35610) |
| PP121 (CHEBI:50915) has role antineoplastic agent (CHEBI:35610) |
| pracinostat (CHEBI:95071) has role antineoplastic agent (CHEBI:35610) |
| pralatrexate (CHEBI:71223) has role antineoplastic agent (CHEBI:35610) |
| prednisolone (CHEBI:8378) has role antineoplastic agent (CHEBI:35610) |
| prednisolone phosphate (CHEBI:145705) has role antineoplastic agent (CHEBI:35610) |
| prednisone (CHEBI:8382) has role antineoplastic agent (CHEBI:35610) |
| prenylcandidusin A (CHEBI:67530) has role antineoplastic agent (CHEBI:35610) |
| prenylcandidusin B (CHEBI:67531) has role antineoplastic agent (CHEBI:35610) |
| prenylcandidusin C (CHEBI:67532) has role antineoplastic agent (CHEBI:35610) |
| prenylterphenyllin (CHEBI:67533) has role antineoplastic agent (CHEBI:35610) |
| prenylterphenyllin A (CHEBI:67526) has role antineoplastic agent (CHEBI:35610) |
| prenylterphenyllin B (CHEBI:67527) has role antineoplastic agent (CHEBI:35610) |
| prenylterphenyllin C (CHEBI:67528) has role antineoplastic agent (CHEBI:35610) |
| prinomastat (CHEBI:138885) has role antineoplastic agent (CHEBI:35610) |
| prinomastat hydrochloride (CHEBI:138841) has role antineoplastic agent (CHEBI:35610) |
| procarbazine (CHEBI:71417) has role antineoplastic agent (CHEBI:35610) |
| procarbazine hydrochloride (CHEBI:71428) has role antineoplastic agent (CHEBI:35610) |
| procyanidin B4 (CHEBI:27589) has role antineoplastic agent (CHEBI:35610) |
| prodigiosin (CHEBI:82758) has role antineoplastic agent (CHEBI:35610) |
| proINDY (CHEBI:195315) has role antineoplastic agent (CHEBI:35610) |
| promegestone (CHEBI:73390) has role antineoplastic agent (CHEBI:35610) |
| prostaglandin J3 (CHEBI:140267) has role antineoplastic agent (CHEBI:35610) |
| protodioscin (CHEBI:8588) has role antineoplastic agent (CHEBI:35610) |
| protopanaxadiol (CHEBI:76238) has role antineoplastic agent (CHEBI:35610) |
| PS-1145 (CHEBI:94801) has role antineoplastic agent (CHEBI:35610) |
| psorospermin (CHEBI:8617) has role antineoplastic agent (CHEBI:35610) |
| pterostilbene (CHEBI:8630) has role antineoplastic agent (CHEBI:35610) |
| punicalagin (CHEBI:167695) has role antineoplastic agent (CHEBI:35610) |
| purine-6-thiol (CHEBI:2208) has role antineoplastic agent (CHEBI:35610) |
| puromycin (CHEBI:17939) has role antineoplastic agent (CHEBI:35610) |
| PYR-41 (CHEBI:192973) has role antineoplastic agent (CHEBI:35610) |
| pyridoxatin (CHEBI:84035) has role antineoplastic agent (CHEBI:35610) |
| pyrrolidine dithiocarbamate (CHEBI:78782) has role antineoplastic agent (CHEBI:35610) |
| pyrvinium (CHEBI:8687) has role antineoplastic agent (CHEBI:35610) |
| quassimarin (CHEBI:8691) has role antineoplastic agent (CHEBI:35610) |
| quercetin (CHEBI:16243) has role antineoplastic agent (CHEBI:35610) |
| quercetin 3-O-β-D-glucopyranoside (CHEBI:68352) has role antineoplastic agent (CHEBI:35610) |
| quercetin 3,4'-dimethyl ether (CHEBI:70008) has role antineoplastic agent (CHEBI:35610) |
| quercetin 4'-O-β-D-glucopyranoside (CHEBI:75839) has role antineoplastic agent (CHEBI:35610) |
| quisinostat (CHEBI:94771) has role antineoplastic agent (CHEBI:35610) |
| quizartinib (CHEBI:90217) has role antineoplastic agent (CHEBI:35610) |
| rafoxanide (CHEBI:234200) has role antineoplastic agent (CHEBI:35610) |
| ravidomycin (CHEBI:84037) has role antineoplastic agent (CHEBI:35610) |
| rediocide G (CHEBI:66296) has role antineoplastic agent (CHEBI:35610) |
| regorafenib (CHEBI:68647) has role antineoplastic agent (CHEBI:35610) |
| regorafenib hydrate (CHEBI:68646) has role antineoplastic agent (CHEBI:35610) |
| repotrectinib (CHEBI:229220) has role antineoplastic agent (CHEBI:35610) |
| RepSox (CHEBI:190969) has role antineoplastic agent (CHEBI:35610) |
| resminostat (CHEBI:231352) has role antineoplastic agent (CHEBI:35610) |
| respirantin (CHEBI:66299) has role antineoplastic agent (CHEBI:35610) |
| retaspimycin (CHEBI:71975) has role antineoplastic agent (CHEBI:35610) |
| retaspimycin hydrochloride (CHEBI:71956) has role antineoplastic agent (CHEBI:35610) |
| reumycin (CHEBI:121196) has role antineoplastic agent (CHEBI:35610) |
| reversine (CHEBI:70723) has role antineoplastic agent (CHEBI:35610) |
| RG-2833 (CHEBI:233052) has role antineoplastic agent (CHEBI:35610) |
| rhamnacene (CHEBI:133721) has role antineoplastic agent (CHEBI:35610) |
| rhapontigenin (CHEBI:174376) has role antineoplastic agent (CHEBI:35610) |
| rhinacanthin C (CHEBI:66303) has role antineoplastic agent (CHEBI:35610) |
| rhizoxin (CHEBI:72590) has role antineoplastic agent (CHEBI:35610) |
| rhosin (CHEBI:137693) has role antineoplastic agent (CHEBI:35610) |
| ricolinostat (CHEBI:95073) has role antineoplastic agent (CHEBI:35610) |
| ridaforolimus (CHEBI:82677) has role antineoplastic agent (CHEBI:35610) |
| rifampicin (CHEBI:28077) has role antineoplastic agent (CHEBI:35610) |
| rigosertib (CHEBI:145417) has role antineoplastic agent (CHEBI:35610) |
| rigosertib sodium (CHEBI:145421) has role antineoplastic agent (CHEBI:35610) |
| riviciclib (CHEBI:231364) has role antineoplastic agent (CHEBI:35610) |
| Ro 48-8071 (CHEBI:101064) has role antineoplastic agent (CHEBI:35610) |
| Ro 48-8071 fumarate (CHEBI:101097) has role antineoplastic agent (CHEBI:35610) |
| Ro 5-3335 (CHEBI:131785) has role antineoplastic agent (CHEBI:35610) |
| robustaflavone (CHEBI:8881) has role antineoplastic agent (CHEBI:35610) |
| robustaflavone 7,4',7''-trimethyl ether (CHEBI:66308) has role antineoplastic agent (CHEBI:35610) |
| rocaglamide (CHEBI:66309) has role antineoplastic agent (CHEBI:35610) |
| roducitabine (CHEBI:147412) has role antineoplastic agent (CHEBI:35610) |
| rohitukine (CHEBI:156498) has role antineoplastic agent (CHEBI:35610) |
| romidepsin (CHEBI:61080) has role antineoplastic agent (CHEBI:35610) |
| rostratin A (CHEBI:66310) has role antineoplastic agent (CHEBI:35610) |
| rostratin B (CHEBI:66311) has role antineoplastic agent (CHEBI:35610) |
| rostratin C (CHEBI:66312) has role antineoplastic agent (CHEBI:35610) |
| rostratin D (CHEBI:66313) has role antineoplastic agent (CHEBI:35610) |
| rotenone (CHEBI:28201) has role antineoplastic agent (CHEBI:35610) |
| rottlerin (CHEBI:8899) has role antineoplastic agent (CHEBI:35610) |
| rotundifolioside A (CHEBI:66314) has role antineoplastic agent (CHEBI:35610) |
| rotundifolioside H (CHEBI:66315) has role antineoplastic agent (CHEBI:35610) |
| rotundifolioside I (CHEBI:66316) has role antineoplastic agent (CHEBI:35610) |
| rotundifolioside J (CHEBI:66317) has role antineoplastic agent (CHEBI:35610) |
| rotundifuran (CHEBI:91265) has role antineoplastic agent (CHEBI:35610) |
| RSL3 (CHEBI:173109) has role antineoplastic agent (CHEBI:35610) |
| RSL5 (CHEBI:176418) has role antineoplastic agent (CHEBI:35610) |
| RU 58668 (CHEBI:90223) has role antineoplastic agent (CHEBI:35610) |
| rubiarbonol G (CHEBI:69518) has role antineoplastic agent (CHEBI:35610) |
| rubiarbonone E 19-acetate (CHEBI:69505) has role antineoplastic agent (CHEBI:35610) |
| rubiarboside G 28-acetate (CHEBI:69508) has role antineoplastic agent (CHEBI:35610) |
| rubimaillin (CHEBI:141063) has role antineoplastic agent (CHEBI:35610) |
| rubitecan (CHEBI:90225) has role antineoplastic agent (CHEBI:35610) |
| rubiyunnanol A (CHEBI:69501) has role antineoplastic agent (CHEBI:35610) |
| rubiyunnanol B (CHEBI:69502) has role antineoplastic agent (CHEBI:35610) |
| rubraxanthone (CHEBI:66318) has role antineoplastic agent (CHEBI:35610) |
| rucaparib (CHEBI:134689) has role antineoplastic agent (CHEBI:35610) |
| ruxolitinib (CHEBI:66919) has role antineoplastic agent (CHEBI:35610) |
| ruxolitinib phosphate (CHEBI:66917) has role antineoplastic agent (CHEBI:35610) |
| ryuvidine (CHEBI:92119) has role antineoplastic agent (CHEBI:35610) |
| safranal (CHEBI:53169) has role antineoplastic agent (CHEBI:35610) |
| saintopin (CHEBI:91276) has role antineoplastic agent (CHEBI:35610) |
| salinosporamide A (CHEBI:48045) has role antineoplastic agent (CHEBI:35610) |
| salsalate (CHEBI:9014) has role antineoplastic agent (CHEBI:35610) |
| salvianolic acid B (CHEBI:134301) has role antineoplastic agent (CHEBI:35610) |
| salvigenin (CHEBI:192703) has role antineoplastic agent (CHEBI:35610) |
| salvileucalin B (CHEBI:66154) has role antineoplastic agent (CHEBI:35610) |
| samaderine B (CHEBI:66159) has role antineoplastic agent (CHEBI:35610) |
| samaderine C (CHEBI:66160) has role antineoplastic agent (CHEBI:35610) |
| samaderine E (CHEBI:66161) has role antineoplastic agent (CHEBI:35610) |
| samaderine X (CHEBI:66162) has role antineoplastic agent (CHEBI:35610) |
| samaderine Y (CHEBI:66163) has role antineoplastic agent (CHEBI:35610) |
| samaderine Z (CHEBI:66164) has role antineoplastic agent (CHEBI:35610) |
| sapacitabine (CHEBI:145429) has role antineoplastic agent (CHEBI:35610) |
| sapanisertib (CHEBI:91450) has role antineoplastic agent (CHEBI:35610) |
| saracatinib (CHEBI:47458) has role antineoplastic agent (CHEBI:35610) |
| satraplatin (CHEBI:85609) has role antineoplastic agent (CHEBI:35610) |
| savolitinib (CHEBI:231369) has role antineoplastic agent (CHEBI:35610) |
| SB-743921 (CHEBI:231716) has role antineoplastic agent (CHEBI:35610) |
| SB225002 (CHEBI:93074) has role antineoplastic agent (CHEBI:35610) |
| SC-58125 (CHEBI:8983) has role antineoplastic agent (CHEBI:35610) |
| SC560 (CHEBI:76274) has role antineoplastic agent (CHEBI:35610) |
| SCH51344 (CHEBI:77556) has role antineoplastic agent (CHEBI:35610) |
| SCH772984 (CHEBI:167670) has role antineoplastic agent (CHEBI:35610) |
| schiprolactone A (CHEBI:66430) has role antineoplastic agent (CHEBI:35610) |
| schizolaenone A (CHEBI:66433) has role antineoplastic agent (CHEBI:35610) |
| schizolaenone B (CHEBI:66434) has role antineoplastic agent (CHEBI:35610) |
| schweinfurthin G (CHEBI:66437) has role antineoplastic agent (CHEBI:35610) |
| schweinfurthin H (CHEBI:66438) has role antineoplastic agent (CHEBI:35610) |
| sciscllascilloside E-1 (CHEBI:66439) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine C (CHEBI:66443) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine D (CHEBI:66444) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine E (CHEBI:66445) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine F (CHEBI:66446) has role antineoplastic agent (CHEBI:35610) |
| scutebarbatine G (CHEBI:66447) has role antineoplastic agent (CHEBI:35610) |
| scutellarin (CHEBI:61278) has role antineoplastic agent (CHEBI:35610) |
| scutianthraquinone A (CHEBI:66453) has role antineoplastic agent (CHEBI:35610) |
| scutianthraquinone B (CHEBI:66454) has role antineoplastic agent (CHEBI:35610) |
| scutianthraquinone C (CHEBI:66455) has role antineoplastic agent (CHEBI:35610) |
| scytalidamide A (CHEBI:66456) has role antineoplastic agent (CHEBI:35610) |
| scytalidamide B (CHEBI:66457) has role antineoplastic agent (CHEBI:35610) |
| secoaggregatalactone A (CHEBI:66458) has role antineoplastic agent (CHEBI:35610) |
| selinexor (CHEBI:229764) has role antineoplastic agent (CHEBI:35610) |
| selumetinib (CHEBI:90227) has role antineoplastic agent (CHEBI:35610) |
| semaxanib (CHEBI:91083) has role antineoplastic agent (CHEBI:35610) |
| semustine (CHEBI:6863) has role antineoplastic agent (CHEBI:35610) |
| sepantronium bromide (CHEBI:139608) has role antineoplastic agent (CHEBI:35610) |
| sesterstatin 1 (CHEBI:66475) has role antineoplastic agent (CHEBI:35610) |
| sesterstatin 2 (CHEBI:66476) has role antineoplastic agent (CHEBI:35610) |
| sesterstatin 3 (CHEBI:66477) has role antineoplastic agent (CHEBI:35610) |
| SF2523 (CHEBI:231676) has role antineoplastic agent (CHEBI:35610) |
| Sg17-1-4 (CHEBI:66478) has role antineoplastic agent (CHEBI:35610) |
| SH-1242 (CHEBI:231663) has role antineoplastic agent (CHEBI:35610) |
| SHP099 (CHEBI:234265) has role antineoplastic agent (CHEBI:35610) |
| sibiromycin (CHEBI:90941) has role antineoplastic agent (CHEBI:35610) |
| silibinin (CHEBI:9144) has role antineoplastic agent (CHEBI:35610) |
| silvestrol (CHEBI:66484) has role antineoplastic agent (CHEBI:35610) |
| simalikalactone D (CHEBI:66486) has role antineoplastic agent (CHEBI:35610) |
| sinularolide B (CHEBI:66507) has role antineoplastic agent (CHEBI:35610) |
| sinularolide C (CHEBI:66508) has role antineoplastic agent (CHEBI:35610) |
| sinularolide D (CHEBI:66509) has role antineoplastic agent (CHEBI:35610) |
| sinularolide E (CHEBI:66510) has role antineoplastic agent (CHEBI:35610) |
| sirolimus (CHEBI:9168) has role antineoplastic agent (CHEBI:35610) |
| sitoindoside IX (CHEBI:69119) has role antineoplastic agent (CHEBI:35610) |
| SKF-96365 hydrochloride (CHEBI:145121) has role antineoplastic agent (CHEBI:35610) |
| SLC-0111 (CHEBI:232342) has role antineoplastic agent (CHEBI:35610) |
| SM-164 (CHEBI:192710) has role antineoplastic agent (CHEBI:35610) |
| SMIP004 (CHEBI:230532) has role antineoplastic agent (CHEBI:35610) |
| SN-38 (CHEBI:8988) has role antineoplastic agent (CHEBI:35610) |
| SNC-80 (CHEBI:231727) has role antineoplastic agent (CHEBI:35610) |
| soblidotin (CHEBI:32135) has role antineoplastic agent (CHEBI:35610) |
| sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has role antineoplastic agent (CHEBI:35610) |
| sodium arsenite (CHEBI:29678) has role antineoplastic agent (CHEBI:35610) |
| sodium gallate (CHEBI:115197) has role antineoplastic agent (CHEBI:35610) |
| sodium globostellatate A (CHEBI:65969) has role antineoplastic agent (CHEBI:35610) |
| sodium globostellatate B (CHEBI:65970) has role antineoplastic agent (CHEBI:35610) |
| sodium globostellatate C (CHEBI:65971) has role antineoplastic agent (CHEBI:35610) |
| sodium globostellatate D (CHEBI:65972) has role antineoplastic agent (CHEBI:35610) |
| sodium meclofenamate monohydrate (CHEBI:76232) has role antineoplastic agent (CHEBI:35610) |
| sodium methoxyacetate (CHEBI:132096) has role antineoplastic agent (CHEBI:35610) |
| sodium stibogluconate (CHEBI:28148) has role antineoplastic agent (CHEBI:35610) |
| solanine (CHEBI:9188) has role antineoplastic agent (CHEBI:35610) |
| solasodine(1+) (CHEBI:145043) has role antineoplastic agent (CHEBI:35610) |
| somocystinamide A (CHEBI:66512) has role antineoplastic agent (CHEBI:35610) |
| sonidegib (CHEBI:90863) has role antineoplastic agent (CHEBI:35610) |
| sonidegib phosphate (CHEBI:90864) has role antineoplastic agent (CHEBI:35610) |
| sophoraflavanone A (CHEBI:70023) has role antineoplastic agent (CHEBI:35610) |
| sophoraflavanone L (CHEBI:66513) has role antineoplastic agent (CHEBI:35610) |
| sorafenib (CHEBI:50924) has role antineoplastic agent (CHEBI:35610) |
| sotorasib (CHEBI:178199) has role antineoplastic agent (CHEBI:35610) |
| spiculoic acid A (CHEBI:66520) has role antineoplastic agent (CHEBI:35610) |
| spiruchostatin B (CHEBI:90235) has role antineoplastic agent (CHEBI:35610) |
| spongotine A (CHEBI:144086) has role antineoplastic agent (CHEBI:35610) |
| SR11302 (CHEBI:197438) has role antineoplastic agent (CHEBI:35610) |
| SR9243 (CHEBI:90842) has role antineoplastic agent (CHEBI:35610) |
| SSTC3 (CHEBI:232382) has role antineoplastic agent (CHEBI:35610) |
| stachsterol (CHEBI:66521) has role antineoplastic agent (CHEBI:35610) |
| stattic (CHEBI:86989) has role antineoplastic agent (CHEBI:35610) |
| steffimycin D (CHEBI:156294) has role antineoplastic agent (CHEBI:35610) |
| steviol (CHEBI:145024) has role antineoplastic agent (CHEBI:35610) |
| stevioside (CHEBI:9271) has role antineoplastic agent (CHEBI:35610) |
| STM2457 (CHEBI:172325) has role antineoplastic agent (CHEBI:35610) |
| streptokordin (CHEBI:66524) has role antineoplastic agent (CHEBI:35610) |
| streptonigrin (CHEBI:9287) has role antineoplastic agent (CHEBI:35610) |
| streptozocin (CHEBI:9288) has role antineoplastic agent (CHEBI:35610) |
| strongylin A (CHEBI:66526) has role antineoplastic agent (CHEBI:35610) |
| strongylophorine-26 (CHEBI:66527) has role antineoplastic agent (CHEBI:35610) |
| SU11274 (CHEBI:190974) has role antineoplastic agent (CHEBI:35610) |
| SU4312 (CHEBI:92369) has role antineoplastic agent (CHEBI:35610) |
| SU6656 (CHEBI:91462) has role antineoplastic agent (CHEBI:35610) |
| sugiol (CHEBI:138961) has role antineoplastic agent (CHEBI:35610) |
| sulfopin (CHEBI:231413) has role antineoplastic agent (CHEBI:35610) |
| sulforaphane (CHEBI:47807) has role antineoplastic agent (CHEBI:35610) |
| sulindac (CHEBI:9352) has role antineoplastic agent (CHEBI:35610) |
| sulindac sulfide (CHEBI:75408) has role antineoplastic agent (CHEBI:35610) |
| sunitinib (CHEBI:38940) has role antineoplastic agent (CHEBI:35610) |
| sunitinib malate (CHEBI:232546) has role antineoplastic agent (CHEBI:35610) |
| suramin (CHEBI:45906) has role antineoplastic agent (CHEBI:35610) |
| suramin sodium (CHEBI:9364) has role antineoplastic agent (CHEBI:35610) |
| surfactin (CHEBI:29681) has role antineoplastic agent (CHEBI:35610) |
| surfactin A (CHEBI:71976) has role antineoplastic agent (CHEBI:35610) |
| surfactin B (CHEBI:71977) has role antineoplastic agent (CHEBI:35610) |
| surfactin C (CHEBI:71978) has role antineoplastic agent (CHEBI:35610) |
| surfactin D (CHEBI:71979) has role antineoplastic agent (CHEBI:35610) |
| swainsonine (CHEBI:9367) has role antineoplastic agent (CHEBI:35610) |
| SYC-435 (CHEBI:189826) has role antineoplastic agent (CHEBI:35610) |
| SZL-P1-41 (CHEBI:75919) has role antineoplastic agent (CHEBI:35610) |
| tabernaemontanine (CHEBI:142075) has role antineoplastic agent (CHEBI:35610) |
| tabersonine (CHEBI:16776) has role antineoplastic agent (CHEBI:35610) |
| tacalcitol (CHEBI:32176) has role antineoplastic agent (CHEBI:35610) |
| tacedinaline (CHEBI:90195) has role antineoplastic agent (CHEBI:35610) |
| taiwanhomoflavone A (CHEBI:66182) has role antineoplastic agent (CHEBI:35610) |
| taiwanhomoflavone-B (CHEBI:66183) has role antineoplastic agent (CHEBI:35610) |
| taiwanin C (CHEBI:191411) has role antineoplastic agent (CHEBI:35610) |
| TAK-580 (CHEBI:167672) has role antineoplastic agent (CHEBI:35610) |
| TAK-632 (CHEBI:167673) has role antineoplastic agent (CHEBI:35610) |
| TAK-733 (CHEBI:231366) has role antineoplastic agent (CHEBI:35610) |
| talaroconvolutin A (CHEBI:173105) has role antineoplastic agent (CHEBI:35610) |
| talmapimod (CHEBI:90683) has role antineoplastic agent (CHEBI:35610) |
| tamibarotene (CHEBI:32181) has role antineoplastic agent (CHEBI:35610) |
| tamoxifen (CHEBI:41774) has role antineoplastic agent (CHEBI:35610) |
| tamsulosin (CHEBI:9398) has role antineoplastic agent (CHEBI:35610) |
| tamsulosin hydrochloride (CHEBI:9399) has role antineoplastic agent (CHEBI:35610) |
| tanariflavanone D (CHEBI:66191) has role antineoplastic agent (CHEBI:35610) |
| tandutinib (CHEBI:90237) has role antineoplastic agent (CHEBI:35610) |
| tanespimycin (CHEBI:64153) has role antineoplastic agent (CHEBI:35610) |
| tangeretin (CHEBI:9400) has role antineoplastic agent (CHEBI:35610) |
| tanghinigenin (CHEBI:74633) has role antineoplastic agent (CHEBI:35610) |
| tanghinin (CHEBI:66192) has role antineoplastic agent (CHEBI:35610) |
| tasisulam (CHEBI:231621) has role antineoplastic agent (CHEBI:35610) |
| tasumatrol E (CHEBI:66194) has role antineoplastic agent (CHEBI:35610) |
| tasumatrol F (CHEBI:66195) has role antineoplastic agent (CHEBI:35610) |
| taurolidine (CHEBI:135173) has role antineoplastic agent (CHEBI:35610) |
| TDZD-8 (CHEBI:147411) has role antineoplastic agent (CHEBI:35610) |
| tectochrysin (CHEBI:9426) has role antineoplastic agent (CHEBI:35610) |
| telatinib (CHEBI:231351) has role antineoplastic agent (CHEBI:35610) |
| temozolomide (CHEBI:72564) has role antineoplastic agent (CHEBI:35610) |
| teniposide (CHEBI:75988) has role antineoplastic agent (CHEBI:35610) |
| tenovin-6 (CHEBI:77729) has role antineoplastic agent (CHEBI:35610) |
| tephrosin (CHEBI:9442) has role antineoplastic agent (CHEBI:35610) |
| terazosin (CHEBI:9445) has role antineoplastic agent (CHEBI:35610) |
| terreic acid (CHEBI:156546) has role antineoplastic agent (CHEBI:35610) |
| terrequinone A (CHEBI:64534) has role antineoplastic agent (CHEBI:35610) |
| tesevatinib (CHEBI:167674) has role antineoplastic agent (CHEBI:35610) |
| tetramethylpyrazine (CHEBI:133246) has role antineoplastic agent (CHEBI:35610) |
| tetrazolium violet (CHEBI:75193) has role antineoplastic agent (CHEBI:35610) |
| TG101209 (CHEBI:90304) has role antineoplastic agent (CHEBI:35610) |
| thalidomide (CHEBI:9513) has role antineoplastic agent (CHEBI:35610) |
| thiodiglycol (CHEBI:75184) has role antineoplastic agent (CHEBI:35610) |
| thiolutin (CHEBI:156450) has role antineoplastic agent (CHEBI:35610) |
| thiostrepton (CHEBI:29693) has role antineoplastic agent (CHEBI:35610) |
| thymoquinone (CHEBI:113532) has role antineoplastic agent (CHEBI:35610) |
| THZ1 (CHEBI:230500) has role antineoplastic agent (CHEBI:35610) |
| THZ531 (CHEBI:143122) has role antineoplastic agent (CHEBI:35610) |
| tiazofurine (CHEBI:90239) has role antineoplastic agent (CHEBI:35610) |
| tigilanol tiglate (CHEBI:194146) has role antineoplastic agent (CHEBI:35610) |
| tilorone (CHEBI:147347) has role antineoplastic agent (CHEBI:35610) |
| tilorone dihydrochloride (CHEBI:147356) has role antineoplastic agent (CHEBI:35610) |
| tioguanine (CHEBI:9555) has role antineoplastic agent (CHEBI:35610) |
| tipifarnib (CHEBI:141969) has role antineoplastic agent (CHEBI:35610) |
| tipiracil (CHEBI:90879) has role antineoplastic agent (CHEBI:35610) |
| tipiracil hydrochloride (CHEBI:90877) has role antineoplastic agent (CHEBI:35610) |
| tirapazamine (CHEBI:78887) has role antineoplastic agent (CHEBI:35610) |
| tirbanibulin (CHEBI:231702) has role antineoplastic agent (CHEBI:35610) |
| tivozanib (CHEBI:91327) has role antineoplastic agent (CHEBI:35610) |
| TMC-135A (CHEBI:66232) has role antineoplastic agent (CHEBI:35610) |
| TMC-135B (CHEBI:66233) has role antineoplastic agent (CHEBI:35610) |
| TMC-1A (CHEBI:66234) has role antineoplastic agent (CHEBI:35610) |
| TMC-1B (CHEBI:66235) has role antineoplastic agent (CHEBI:35610) |
| TMC-1C (CHEBI:66236) has role antineoplastic agent (CHEBI:35610) |
| TMC-1D (CHEBI:66237) has role antineoplastic agent (CHEBI:35610) |
| TMC-86A (CHEBI:66242) has role antineoplastic agent (CHEBI:35610) |
| TMC-86B (CHEBI:66243) has role antineoplastic agent (CHEBI:35610) |
| TMC-95A (CHEBI:40322) has role antineoplastic agent (CHEBI:35610) |
| TMC-95B (CHEBI:66246) has role antineoplastic agent (CHEBI:35610) |
| TMC-95C (CHEBI:66247) has role antineoplastic agent (CHEBI:35610) |
| TMC-95D (CHEBI:66248) has role antineoplastic agent (CHEBI:35610) |
| TMC-96 (CHEBI:66244) has role antineoplastic agent (CHEBI:35610) |
| tomaymycin (CHEBI:157681) has role antineoplastic agent (CHEBI:35610) |
| TOP-53 (CHEBI:134547) has role antineoplastic agent (CHEBI:35610) |
| topopyrone A (CHEBI:66252) has role antineoplastic agent (CHEBI:35610) |
| topopyrone B (CHEBI:66253) has role antineoplastic agent (CHEBI:35610) |
| topopyrone C (CHEBI:66254) has role antineoplastic agent (CHEBI:35610) |
| topopyrone D (CHEBI:66255) has role antineoplastic agent (CHEBI:35610) |
| topotecan (CHEBI:63632) has role antineoplastic agent (CHEBI:35610) |
| topotecan hydrochloride (CHEBI:232548) has role antineoplastic agent (CHEBI:35610) |
| toremifene (CHEBI:9635) has role antineoplastic agent (CHEBI:35610) |
| torin 1 (CHEBI:84327) has role antineoplastic agent (CHEBI:35610) |
| torin 2 (CHEBI:90682) has role antineoplastic agent (CHEBI:35610) |
| torkinib (CHEBI:90679) has role antineoplastic agent (CHEBI:35610) |
| toxoflavin (CHEBI:80729) has role antineoplastic agent (CHEBI:35610) |
| toyocamycin (CHEBI:134606) has role antineoplastic agent (CHEBI:35610) |
| trabectedin (CHEBI:84050) has role antineoplastic agent (CHEBI:35610) |
| trametinib (CHEBI:75998) has role antineoplastic agent (CHEBI:35610) |
| trametinib dimethyl sulfoxide (CHEBI:75991) has role antineoplastic agent (CHEBI:35610) |
| tranilast (CHEBI:77572) has role antineoplastic agent (CHEBI:35610) |
| trapoxin A (CHEBI:84057) has role antineoplastic agent (CHEBI:35610) |
| trehalose 6,6'-dimycolate (CHEBI:82624) has role antineoplastic agent (CHEBI:35610) |
| triapine (CHEBI:231347) has role antineoplastic agent (CHEBI:35610) |
| triaziquone (CHEBI:27090) has role antineoplastic agent (CHEBI:35610) |
| tributyrin (CHEBI:35020) has role antineoplastic agent (CHEBI:35610) |
| tricetin (CHEBI:507499) has role antineoplastic agent (CHEBI:35610) |
| trichodermin (CHEBI:9688) has role antineoplastic agent (CHEBI:35610) |
| trichodimerol (CHEBI:66261) has role antineoplastic agent (CHEBI:35610) |
| trichothecin (CHEBI:69621) has role antineoplastic agent (CHEBI:35610) |
| trierixin (CHEBI:66262) has role antineoplastic agent (CHEBI:35610) |
| trifluridine (CHEBI:75179) has role antineoplastic agent (CHEBI:35610) |
| trilobacin (CHEBI:66270) has role antineoplastic agent (CHEBI:35610) |
| trilostane (CHEBI:32260) has role antineoplastic agent (CHEBI:35610) |
| triplatin tetranitrate (CHEBI:85611) has role antineoplastic agent (CHEBI:35610) |
| triplatin(4+) (CHEBI:85612) has role antineoplastic agent (CHEBI:35610) |
| triptonide (CHEBI:132267) has role antineoplastic agent (CHEBI:35610) |
| triptorelin (CHEBI:63633) has role antineoplastic agent (CHEBI:35610) |
| trisodium vanadate (CHEBI:35607) has role antineoplastic agent (CHEBI:35610) |
| troglitazone (CHEBI:9753) has role antineoplastic agent (CHEBI:35610) |
| tschimganine (CHEBI:142517) has role antineoplastic agent (CHEBI:35610) |
| tsugarioside C (CHEBI:66278) has role antineoplastic agent (CHEBI:35610) |
| TTT-3002 (CHEBI:88219) has role antineoplastic agent (CHEBI:35610) |
| tubercidin (CHEBI:48267) has role antineoplastic agent (CHEBI:35610) |
| tubocapsanolide A (CHEBI:66325) has role antineoplastic agent (CHEBI:35610) |
| tubocapsanolide F (CHEBI:66328) has role antineoplastic agent (CHEBI:35610) |
| tubulozole (CHEBI:83928) has role antineoplastic agent (CHEBI:35610) |
| TW-37 (CHEBI:95008) has role antineoplastic agent (CHEBI:35610) |
| tyrphostin AG 1478 (CHEBI:75404) has role antineoplastic agent (CHEBI:35610) |
| U0126 (CHEBI:90693) has role antineoplastic agent (CHEBI:35610) |
| U0126.EtOH (CHEBI:90692) has role antineoplastic agent (CHEBI:35610) |
| ubiquinol-8 (CHEBI:61682) has role antineoplastic agent (CHEBI:35610) |
| UCS1025 A (CHEBI:66338) has role antineoplastic agent (CHEBI:35610) |
| UNC0638 (CHEBI:95074) has role antineoplastic agent (CHEBI:35610) |
| UNC0642 (CHEBI:233643) has role antineoplastic agent (CHEBI:35610) |
| undecylprodigiosin (CHEBI:29702) has role antineoplastic agent (CHEBI:35610) |
| urdamycin A (CHEBI:32279) has role antineoplastic agent (CHEBI:35610) |
| uvaretin (CHEBI:9915) has role antineoplastic agent (CHEBI:35610) |
| vadimezan (CHEBI:75934) has role antineoplastic agent (CHEBI:35610) |
| vandetanib (CHEBI:49960) has role antineoplastic agent (CHEBI:35610) |
| variecolorquinone A (CHEBI:66350) has role antineoplastic agent (CHEBI:35610) |
| variecolorquinone B (CHEBI:66351) has role antineoplastic agent (CHEBI:35610) |
| varlitinib (CHEBI:231356) has role antineoplastic agent (CHEBI:35610) |
| vatalanib (CHEBI:90620) has role antineoplastic agent (CHEBI:35610) |
| vatalanib succinate (CHEBI:90623) has role antineoplastic agent (CHEBI:35610) |
| vedelianin (CHEBI:66352) has role antineoplastic agent (CHEBI:35610) |
| vemurafenib (CHEBI:63637) has role antineoplastic agent (CHEBI:35610) |
| venetoclax (CHEBI:133021) has role antineoplastic agent (CHEBI:35610) |
| verteporfin (CHEBI:32293) has role antineoplastic agent (CHEBI:35610) |
| vincaleukoblastine (CHEBI:27375) has role antineoplastic agent (CHEBI:35610) |
| vincristine (CHEBI:28445) has role antineoplastic agent (CHEBI:35610) |
| vincristine sulfate (CHEBI:79401) has role antineoplastic agent (CHEBI:35610) |
| vincristine(2+) (CHEBI:143658) has role antineoplastic agent (CHEBI:35610) |
| vindesine (CHEBI:36373) has role antineoplastic agent (CHEBI:35610) |
| vindesine sulfate (CHEBI:32295) has role antineoplastic agent (CHEBI:35610) |
| vinflunine (CHEBI:90241) has role antineoplastic agent (CHEBI:35610) |
| vinorelbine (CHEBI:480999) has role antineoplastic agent (CHEBI:35610) |
| vinorelbine D-tartrate (CHEBI:53750) has role antineoplastic agent (CHEBI:35610) |
| vinorelbine L-tartrate (CHEBI:32296) has role antineoplastic agent (CHEBI:35610) |
| violacein (CHEBI:131914) has role antineoplastic agent (CHEBI:35610) |
| viridicatumtoxin (CHEBI:85616) has role antineoplastic agent (CHEBI:35610) |
| vismodegib (CHEBI:66903) has role antineoplastic agent (CHEBI:35610) |
| vitekwangin B (CHEBI:231954) has role antineoplastic agent (CHEBI:35610) |
| vitetrifolin D (CHEBI:91266) has role antineoplastic agent (CHEBI:35610) |
| vitexilactone (CHEBI:91267) has role antineoplastic agent (CHEBI:35610) |
| vitexin (CHEBI:16954) has role antineoplastic agent (CHEBI:35610) |
| volasertib (CHEBI:231358) has role antineoplastic agent (CHEBI:35610) |
| vorinostat (CHEBI:45716) has role antineoplastic agent (CHEBI:35610) |
| vosaroxin (CHEBI:231651) has role antineoplastic agent (CHEBI:35610) |
| VTP-50469 (CHEBI:232861) has role antineoplastic agent (CHEBI:35610) |
| wedelolactone (CHEBI:10037) has role antineoplastic agent (CHEBI:35610) |
| withaferin A (CHEBI:69120) has role antineoplastic agent (CHEBI:35610) |
| withalongolide A (CHEBI:69106) has role antineoplastic agent (CHEBI:35610) |
| withalongolide B (CHEBI:69107) has role antineoplastic agent (CHEBI:35610) |
| withalongolide C (CHEBI:69108) has role antineoplastic agent (CHEBI:35610) |
| withalongolide G (CHEBI:69126) has role antineoplastic agent (CHEBI:35610) |
| withalongolide H (CHEBI:69112) has role antineoplastic agent (CHEBI:35610) |
| withanolide D (CHEBI:10041) has role antineoplastic agent (CHEBI:35610) |
| Wnt-C59 (CHEBI:235513) has role antineoplastic agent (CHEBI:35610) |
| wogonin (CHEBI:10043) has role antineoplastic agent (CHEBI:35610) |
| wortmannin (CHEBI:52289) has role antineoplastic agent (CHEBI:35610) |
| wrightiamine A (CHEBI:66330) has role antineoplastic agent (CHEBI:35610) |
| WYE-28 (CHEBI:234113) has role antineoplastic agent (CHEBI:35610) |
| WZ4002 (CHEBI:61400) has role antineoplastic agent (CHEBI:35610) |
| WZB-117 (CHEBI:229781) has role antineoplastic agent (CHEBI:35610) |
| xanthohumol (CHEBI:66331) has role antineoplastic agent (CHEBI:35610) |
| xanthomicrol (CHEBI:35047) has role antineoplastic agent (CHEBI:35610) |
| xestospongin C (CHEBI:131784) has role antineoplastic agent (CHEBI:35610) |
| XL147 (CHEBI:71957) has role antineoplastic agent (CHEBI:35610) |
| XL413 (CHEBI:189662) has role antineoplastic agent (CHEBI:35610) |
| XL765 (CHEBI:71958) has role antineoplastic agent (CHEBI:35610) |
| XMD-17-51 (CHEBI:234455) has role antineoplastic agent (CHEBI:35610) |
| XPO1-IN-1 (CHEBI:229765) has role antineoplastic agent (CHEBI:35610) |
| xylocarpin J (CHEBI:66337) has role antineoplastic agent (CHEBI:35610) |
| yadanziolide B (CHEBI:68932) has role antineoplastic agent (CHEBI:35610) |
| yadanziolide T (CHEBI:68928) has role antineoplastic agent (CHEBI:35610) |
| yahyaxanthone (CHEBI:66491) has role antineoplastic agent (CHEBI:35610) |
| YK-4-279 (CHEBI:94301) has role antineoplastic agent (CHEBI:35610) |
| YM-216391 (CHEBI:169951) has role antineoplastic agent (CHEBI:35610) |
| YXG-158 (CHEBI:228303) has role antineoplastic agent (CHEBI:35610) |
| zarzissine (CHEBI:66501) has role antineoplastic agent (CHEBI:35610) |
| zhankuic acid A (CHEBI:66503) has role antineoplastic agent (CHEBI:35610) |
| zhankuic acid B (CHEBI:66504) has role antineoplastic agent (CHEBI:35610) |
| zhankuic acid C (CHEBI:66505) has role antineoplastic agent (CHEBI:35610) |
| zibotentan (CHEBI:94573) has role antineoplastic agent (CHEBI:35610) |
| zipalertinib (CHEBI:233402) has role antineoplastic agent (CHEBI:35610) |
| ZM447439 (CHEBI:91376) has role antineoplastic agent (CHEBI:35610) |
| ZSTK-474 (CHEBI:90545) has role antineoplastic agent (CHEBI:35610) |
| α-(4-hydroxyphenyl)-N-tert-butylnitrone (CHEBI:77433) has role antineoplastic agent (CHEBI:35610) |
| α-mangostin (CHEBI:67547) has role antineoplastic agent (CHEBI:35610) |
| α-peltatin (CHEBI:10324) has role antineoplastic agent (CHEBI:35610) |
| α-tocopheryloxyacetic acid (CHEBI:194185) has role antineoplastic agent (CHEBI:35610) |
| β-aminopropionitrile (CHEBI:27413) has role antineoplastic agent (CHEBI:35610) |
| β-aminopropionitrile hemifumarate (CHEBI:91084) has role antineoplastic agent (CHEBI:35610) |
| β-elemene (CHEBI:62854) has role antineoplastic agent (CHEBI:35610) |
| β-lapachone (CHEBI:10429) has role antineoplastic agent (CHEBI:35610) |
| β-peltatin (CHEBI:74867) has role antineoplastic agent (CHEBI:35610) |
| β-thujaplicin (CHEBI:10447) has role antineoplastic agent (CHEBI:35610) |
| β-tocotrienol (CHEBI:33275) has role antineoplastic agent (CHEBI:35610) |
| γ-glutamyl-Se-methylselenocysteine (CHEBI:28776) has role antineoplastic agent (CHEBI:35610) |
| γ-mangostin (CHEBI:67548) has role antineoplastic agent (CHEBI:35610) |
| γ-tocotrienol (CHEBI:33277) has role antineoplastic agent (CHEBI:35610) |
| δ-tocotrienol (CHEBI:33276) has role antineoplastic agent (CHEBI:35610) |
| Δ12-prostaglandin J3 (CHEBI:140274) has role antineoplastic agent (CHEBI:35610) |
